Parodontitis or/and operation codes

K11_PARODON_OPER_DENTAL_OPER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions K11_DENTAL_OPER	290470
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints K11_PARODON_OPER	46824
6. Filter based on genotype QC (FinnGen only)	46824

Control definitions (FinnGen only)

Control exclude: K11_PARODON_OPER
Control conditions: K11_DENTAL_OPER

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_PARODON_OPER_DENTAL_OPER
CONTROL_EXCLUDE	K11_PARODON_OPER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	K11_DENTAL_OPER
SEX
INCLUDE	K11_PARODON_OPER
PRE_CONDITIONS
CONDITIONS	K11_DENTAL_OPER
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Parodontitis or/and operation codes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	274134	137809	134146
Only index persons	270355	137119	133236
Unadjusted period prevalence (%)
Whole population	3.84	3.95	3.75
Only index persons	5.06	5.04	5.09
Median age at first event (years)
Whole population	59.81	60.84	59.11
Only index persons	59.99	60.85	59.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	46824	25077	21747
Unadjusted period prevalence (%)	9.03	8.55	9.59
Median age at first event (years)	62.72	61.57	64.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9695: Matched controls
77265

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

2.5

323.0

6022

30547

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

5.7

323.0

1342

2134

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.4

323.0

5722

28663

K05.31

ICD-10 Finland

Periodontitis pronounced

+∞

323.0

3772

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

3.5

323.0

4808

16862

K05.30

ICD-10 Finland

Periodontitis complex

+∞

323.0

7053

SDA12

NOMESCO Finland

Treatment of complicated periodontal disease

120.9

323.0

435

EBA00

NOMESCO Finland

Extraction of tooth

2.3

303.2

4393

20451

K05.3

ICD-10 Finland

Chronic periodontitis

6.3

252.7

745

1004

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

225.5

7111

43800

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

3.0

214.9

1434

4183

SDA

NOMESCO Finland

Treatment of periodontitis and gingival lesions

60.1

208.1

264

WX110

NOMESCO Finland

Local anesthesy

2.3

190.2

8373

56660

WZA90

NOMESCO Finland

Other doctors statement

2.0

186.6

3167

14885

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

2.6

182.0

1580

5382

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.1

179.3

2844

12955

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

2.0

172.4

2880

13355

SBA00

NOMESCO Finland

Microbiological examinations

7.6

168.8

433

473

SDA02

NOMESCO Finland

Parodonthologic therapy

1.8

150.1

4593

26018

WX290

NOMESCO Finland

Other blockade of nerve

1.8

146.6

6636

42354

SAA01

NOMESCO Finland

Simple examination of mouth

2.2

144.7

8666

61063

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.1

141.4

890

2451

K05.38

ICD-10 Finland

Other chronic periodontitis

7.8

141.2

356

378

K02.1

ICD-10 Finland

Caries of dentine

1.9

130.7

7855

53694

K05.4

ICD-10 Finland

Periodontosis

+∞

123.2

129

SAAPA

NOMESCO Finland

19.3

121.9

200

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

115.9

2363

11470

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

114.4

3806

21490

N07BA03

ATC

varenicline; oral

2.9

113.3

778

2260

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.7

112.7

3386

18540

SDA13

NOMESCO Finland

Treatment of complicated periodontal disease, extensive and demanding

89.5

101.5

122

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

93.8

3604

20812

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.5

90.0

348

632

K05.39

ICD-10 Finland

Periodontitis UNS

6.7

84.0

232

282

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

83.5

4579

28543

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

79.2

691

2298

ECA50

NOMESCO Finland

Parodontal operation

17.9

77.1

129

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

73.4

5825

38866

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

70.5

1068

4565

N07BB01

ATC

disulfiram; oral

2.6

68.6

546

1721

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

64.7

1272

5953

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

63.9

1282

6040

SDA10

NOMESCO Finland

Parodonthologic therapy of advnaced and complicated changes of alveolar bone

17.3

62.0

105

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

60.6

6756

47252

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

59.1

2307

13025

Z72.0

ICD-10 Finland

Tobacco use

3.4

58.8

305

721

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

58.7

5549

37459

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

58.4

4795

31514

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

57.6

7413

53028

C03CA01

ATC

furosemide; systemic

1.9

57.5

890

3818

D82

ICPC

Teeth/gum disease

1.4

57.4

4560

29746

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

56.7

2919

17483

C08CA01

ATC

amlodipine; oral

1.7

56.0

1301

6394

K03.66

ICD-10 Finland

Tooth plaque

2.1

55.2

664

2571

C10AA01

ATC

simvastatin; oral

1.8

54.7

1065

4950

ECA55

NOMESCO Finland

Complicated parodontal operation

12.6

53.8

103

K08.3

ICD-10 Finland

Retained dental root

2.3

53.4

565

2062

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.0

53.4

729

2977

P01AB01

ATC

metronidazole; oral, rectal

1.4

53.1

3714

23539

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

52.4

1237

6101

N05AH04

ATC

quetiapine; oral

1.6

51.9

1878

10367

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.0

51.5

221

445

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

50.6

2536

15026

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

50.5

1247

6226

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

49.8

1761

9651

K05.28

ICD-10 Finland

Another acute periodontitis

6.2

49.1

141

182

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

48.9

933

4299

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

2.0

48.1

640

2584

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

47.6

2174

12602

SPAT1310

SPAT

Counselling related to known health issue

1.4

47.5

2639

15922

T90

ICPC

Diabetes non-insulin dependent

1.8

46.9

929

4332

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

46.3

835

3772

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

46.2

984

4691

SDC40

NOMESCO Finland

Strong parodontological fixation of 4-6 teeth

26.9

45.5

N05AA02

ATC

levomepromazine; systemic

2.4

43.9

402

1366

ECA70

NOMESCO Finland

Regenerative parodontal operation or gingiva and alveolus transplantation

14.0

43.9

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

43.3

1413

7567

SDA14

NOMESCO Finland

Treatment of complicated periodontal disease, extensive and very demanding

192.2

42.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

42.6

648

2753

SDC10

NOMESCO Finland

Parodontological fixation

8.8

42.4

N02AX02

ATC

tramadol; systemic, rectal

1.4

42.0

2884

18004

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.3

42.0

166

310

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

41.8

211

489

SDC30

NOMESCO Finland

Strong parodontological fixation of 2-3 teeth

12.1

41.3

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

40.4

569

2347

N02BE01

ATC

paracetamol; systemic, rectal

1.4

40.3

7565

55386

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

40.3

250

673

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

40.2

163

312

A10BA02

ATC

metformin; oral

1.6

40.2

1152

5962

S18

ICPC

Laceration/cut

1.4

40.0

2786

17397

C10AA05

ATC

atorvastatin; oral

1.6

39.5

1129

5839

SPAT1216

SPAT

Assessment of functional ability

1.8

39.3

754

3471

EMAK

NOMESCO Finland

2.1

39.3

482

1878

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

39.2

1230

6511

Z3231

NOMESCO Finland

Registered nurse

1.4

39.1

1983

11669

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

38.4

1937

11382

SPAT1283

SPAT

Restricted health certificate

1.4

38.3

2701

16881

SPAT1262

SPAT

Handing over of treatment supplies

1.6

38.2

995

5016

SPE01

NOMESCO Finland

Mucosa-supported partial denture

6.5

38.1

105

129

N05CF01

ATC

zopiclone; oral

1.4

38.0

2106

12596

A02BC02

ATC

pantoprazole; systemic

1.3

37.4

4985

34365

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

37.1

472

1867

K05.20

ICD-10 Finland

Periodontal abscess without fistula

4.4

37.0

142

258

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.0

37.0

532

2209

TK800

NOMESCO Finland

Hemodialysis

3.7

36.6

169

365

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

36.3

1094

5727

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.1

36.1

419

1595

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

36.0

231

637

C09AA05

ATC

ramipril; oral

1.7

36.0

769

3660

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

35.7

2266

22722

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

35.6

817

3968

SPA47

NOMESCO Finland

Precision impression for denture

4.9

35.6

124

204

D19

ICPC

Teeth/gum symptom/complaint

1.3

35.5

3136

20269

M54.5

ICD-10 Finland

Low back pain

1.3

34.6

3101

20068

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

2.2

34.5

382

1423

A10AE04

ATC

insulin glargine; parenteral

1.9

34.5

590

2610

K04.0

ICD-10 Finland

Pulpitis

1.5

34.5

1407

7897

N05CD07

ATC

temazepam; oral

1.9

34.1

521

2212

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

34.1

458

1851

Z94.0

ICD-10 Finland

Kidney transplant status

4.4

33.6

129

235

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

33.1

599

2701

SPAT1301

SPAT

No procedures

1.4

33.1

2380

14850

ECB00

NOMESCO Finland

Suture of gingiva

2.3

33.0

337

1209

EBA30

NOMESCO Finland

Excision of root of tooth

2.2

32.9

377

1424

205

Kela drug reimbursment

Chronic hypertension

1.8

32.9

639

2950

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.7

32.9

967

11051

M79.6

ICD-10 Finland

Pain in limb

1.3

32.8

2905

18726

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

32.7

260

818

N06AB04

ATC

citalopram; systemic

1.4

32.1

1878

11292

127

Kela drug reimbursment

Transplant complication

3.6

32.0

153

341

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

32.0

1567

9116

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.4

32.0

101

149

K05.21

ICD-10 Finland

Periodontal abscess with fistula

5.9

32.0

130

P15

ICPC

Chronic alcohol abuse

2.5

31.9

275

906

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

31.9

1429

8163

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

4.0

31.9

135

271

K05.2

ICD-10 Finland

Acute periodontitis

5.4

31.6

101

151

N05BA01

ATC

diazepam; systemic, rectal

1.6

30.4

934

4901

A11CC03

ATC

alfacalcidol; systemic

3.4

29.8

155

370

N05BA04

ATC

oxazepam; oral

1.4

29.8

2060

12732

EBA00

SPAT

2.8

29.7

199

567

R05

ICPC

Cough

1.4

29.5

1856

11283

N06AX11

ATC

mirtazapine; oral

1.3

29.3

2627

16902

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

29.2

815

4173

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

29.1

638

3054

K04.08

ICD-10 Finland

Other specified pulpit

1.6

28.9

920

4867

C09AA02

ATC

enalapril; systemic

1.7

28.7

630

3017

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.1

28.7

110

SDD01

NOMESCO Finland

Treatment of periodontal bite, restricted

7.7

28.6

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

28.5

499

2225

AA1AD

NOMESCO Finland

CT of head and brain

1.5

28.5

1185

6656

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.5

28.2

106

190

P17

ICPC

Tobacco abuse

3.1

28.2

165

429

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.7

28.0

1010

11152

A12AA04

ATC

calcium carbonate; oral

4.3

27.9

109

203

L04AA06

ATC

mycophenolic acid; systemic

3.0

27.9

170

456

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

27.8

1381

8034

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

27.8

3545

23912

S10

ICPC

Boil/carbuncle

1.9

27.8

450

1954

N18.0

ICD-10 Finland

End-stage renal disease

5.3

27.6

135

L03

ICPC

Low back symptom/complaint

1.3

27.6

2076

12978

N03AG01

ATC

valproic acid; systemic, rectal

1.7

27.5

621

3000

SPAT1263

SPAT

Sampling

1.3

27.3

3767

25651

L28

ICPC

Limited function/disability (L)

1.6

27.2

724

3657

N06AX16

ATC

venlafaxine; oral

1.4

27.2

1472

8699

8511

FHL

Cervical dilation and drainage with suction

2.0

26.8

352

1410

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.1

26.7

111

220

W78

ICPC

Pregnancy

0.7

26.3

1141

12231

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

26.2

1330

7760

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

26.2

1716

10479

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

26.2

107

209

WKPAL

NOMESCO Finland

2.5

26.1

219

711

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

26.1

286

1062

L17

ICPC

Foot/toe symptom/complaint

1.4

26.0

1740

10661

SPAT1153

SPAT

Removal of sutures

1.3

25.9

1929

12019

N05AH03

ATC

olanzapine; systemic

1.6

25.8

677

3407

K02.2

ICD-10 Finland

Caries of cementum

2.2

25.8

272

993

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

25.7

445

1975

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.4

25.7

1201

6898

C10AA07

ATC

rosuvastatin; oral

1.6

25.5

787

4130

SPAT1254

SPAT

Administration of medicine

1.5

25.4

928

5061

SPAT1240

SPAT

Therapeutic discussion

1.4

25.3

1320

7738

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

2.3

25.3

258

926

MAX99

NOMESCO Finland

Assistance to normal delivery

0.7

25.3

672

7861

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.7

25.2

157

N02AA05

ATC

oxycodone; systemic

1.7

25.2

569

2746

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.4

25.1

1839

K85

ICPC

Elevated blood pressure

1.7

25.1

578

2808

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.4

25.1

1165

6682

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

24.7

153

416

C09CA01

ATC

losartan; oral

1.5

24.6

898

4892

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

24.6

1334

7874

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

24.6

2919

27349

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

24.5

3095

20752

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.2

24.2

186

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

24.1

1419

14544

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

24.0

1335

7914

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

23.9

181

SPAT1260

SPAT

Consultation of another employee

1.4

23.8

1263

7420

N03AX16

ATC

pregabalin; oral

1.4

23.8

1581

9663

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

23.7

150

412

J01FA10

ATC

azithromycin; systemic

0.8

23.6

4660

41368

K05.29

ICD-10 Finland

Acute periodontitis UNS

5.7

23.6

100

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

23.5

2001

12701

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.3

23.5

123

297

8513

FHL

Softening of cervix with abortifacient or laminars and associated surgical emptying of the uterus

2.0

23.4

303

1209

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

23.3

935

5200

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

23.3

289

1135

D11

ICPC

Diarrhoea

1.4

23.2

1212

7100

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

23.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

22.9

933

5203

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

22.9

730

3856

SPAT1312

SPAT

General health counselling

1.3

22.9

2678

17747

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

22.8

555

2738

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

22.7

546

2683

-1

NOMESCO Finland

1.2

22.6

4169

29170

T89

ICPC

Diabetes insulin dependent

1.8

22.5

414

1876

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

22.3

1386

8366

R4110

NOMESCO Finland

Physiotherapy

1.3

22.3

1626

10072

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

22.3

478

2273

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

22.2

3722

25739

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

22.1

498

2402

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

4.8

22.1

129

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

22.0

333

1411

J01FF01

ATC

clindamycin; systemic

1.3

21.9

2006

12850

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

21.8

397

1793

G47.3

ICD-10 Finland

Sleep apnoea

1.4

21.8

1326

7971

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.3

21.7

1623

10088

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

7.3

21.6

D10

ICPC

Vomiting

1.5

21.6

743

3993

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

21.5

533

2639

C07AB07

ATC

bisoprolol; oral

1.3

21.5

1950

12469

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

21.5

172

548

K06.18

ICD-10 Finland

Another gingival hyperplasia

8.2

21.4

WX002

NOMESCO Finland

Sedation and analgesia

1.4

21.4

1115

6524

SDD02

NOMESCO Finland

Treatment of periodontal bite

17.5

21.3

N05AF03

ATC

chlorprothixene; systemic

2.0

21.3

278

1115

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.8

21.1

1383

13999

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.7

21.0

151

450

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

20.9

409

1891

WX110

SPAT

1.7

20.9

484

2354

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.4

20.8

177

582

G02BA03

ATC

plastic IUD with progestogen

0.7

20.8

1095

11434

Z37.0

ICD-10 Finland

Single live birth

0.7

20.7

742

8239

Z00.0

ICD-10 Finland

General medical examination

1.4

20.6

1311

7933

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

20.6

390

1784

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

20.6

509

2519

A03

ICPC

Fever

1.3

20.6

1766

11193

N05AX08

ATC

risperidone; systemic

1.6

20.5

614

3190

137

Kela drug reimbursment

Uraemia requiring dialysis

4.2

20.5

151

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

20.4

2411

15952

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

20.4

704

3786

Z49.2

ICD-10 Finland

Other dialysis

5.0

20.2

110

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.6

20.2

154

478

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.8

20.1

378

1727

T84.62

ICD-10 Finland

Osteitis associated with dental implants

9.9

20.1

D10AX03

ATC

azelaic acid; topical

0.7

19.9

540

6307

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.0

19.9

259

1036

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

19.9

507

2530

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

19.9

1710

10838

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.8

19.8

354

1588

B05DA

ATC

Isotonic solutions

4.6

19.8

123

N03AX12

ATC

gabapentin; oral

1.4

19.7

1067

6282

SDA11

NOMESCO Finland

Periodontal treatment, complicated disease – extensive and demanding

175.7

19.7

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.1

19.6

100

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

19.5

6843

50935

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

19.5

707

3844

N05AB03

ATC

perphenazine; systemic, rectal

1.9

19.5

312

1349

L08

ICPC

Shoulder symptom/complaint

1.4

19.5

1187

7129

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

19.5

705

3832

WX105

SPAT

5.0

19.4

105

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

19.3

532

2710

ZXA00

NOMESCO Finland

Right side

1.3

19.3

1351

8298

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.8

19.3

1598

15720

M25.5

ICD-10 Finland

Pain in joint

1.3

19.2

2410

16043

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

19.1

1395

8622

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

19.1

1086

11230

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

19.1

495

2485

ECA30

NOMESCO Finland

Excision of lesion of gingiva

3.2

19.0

107

272

KAY40

NOMESCO Finland

0.4

19.0

1728

Z2446

NOMESCO Finland

Social worker

1.6

19.0

536

2749

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

19.0

3372

23348

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

18.8

122

343

T74.1

ICD-10 Finland

Physical abuse

2.0

18.7

256

1046

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

18.7

1055

6253

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

18.7

475

2371

ZXA05

NOMESCO Finland

Left side

1.4

18.6

1251

7633

L12

ICPC

Hand/finger symptom/complaint

1.4

18.5

1095

6543

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.5

18.5

767

4288

WX872

NOMESCO Finland

Intensive care

2.2

18.3

198

735

L13

ICPC

Hip symptom/complaint

1.5

18.3

721

3990

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

18.2

448

2213

V03AE02

ATC

sevelamer; oral

5.5

18.2

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

18.2

806

4569

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

18.2

410

1981

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.2

18.2

196

725

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

18.1

652

3540

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

18.1

952

5571

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.5

18.0

147

475

L15

ICPC

Knee symptom/complaint

1.3

18.0

1252

7676

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

17.9

486

2466

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.4

17.8

205

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

17.8

408

1980

TMA00

NOMESCO Finland

Episiotomy

0.5

17.8

134

2148

A06AD11

ATC

lactulose; oral

1.5

17.7

578

3068

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

9.2

17.6

A10AA02

ATC

1.8

17.5

297

1312

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.9

17.5

111

309

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

17.4

612

3306

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.3

17.4

122

A10AA01

ATC

1.8

17.3

292

1288

A10AE06

ATC

insulin degludec; parenteral

1.9

17.2

262

1114

N06AX21

ATC

duloxetine; oral

1.4

17.2

949

5599

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

17.2

113

322

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.5

17.1

141

458

A46

ICD-10 Finland

Erysipelas

1.5

17.1

573

3061

R06.0

ICD-10 Finland

Dyspnoea

1.3

17.0

1372

8596

E66.8

ICD-10 Finland

Other obesity

1.5

17.0

537

2828

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

17.0

1377

8632

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.5

17.0

648

3561

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

16.8

819

4721

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.2

16.8

126

HMAK

NOMESCO Finland

1.3

16.7

1469

9317

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.0

16.7

209

827

SPA51

NOMESCO Finland

Determination of bite and dental arch location, demanding

6.2

16.7

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

16.6

295

1323

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

16.6

1055

6368

N05AX12

ATC

aripiprazole; systemic

1.5

16.6

514

2696

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.7

16.5

338

1587

A01

ICPC

Pain general/multiple sites

1.5

16.5

522

2754

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

16.4

228

939

A10AE05

ATC

insulin detemir; parenteral

1.7

16.4

366

1762

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

16.4

267

B05DB

ATC

Hypertonic solutions

4.5

16.3

104

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.3

16.3

1259

7836

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

16.3

1024

6172

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.5

16.1

132

428

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

16.1

527

2800

P16

ICPC

Acute alcohol abuse

2.4

16.1

146

498

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

16.1

402

1995

A28

ICPC

Limited function/disability NOS

1.6

16.1

424

2135

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

16.1

661

3690

WX892

NOMESCO Finland

Monitored bed care

1.7

16.1

344

1636

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

16.0

604

3309

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

16.0

887

5233

K04.09

ICD-10 Finland

Pulpit UNS

1.5

16.0

512

2705

K86

ICPC

Hypertension uncomplicated

1.8

16.0

293

1328

R02

ICPC

Shortness of breath/dyspnoea

1.4

15.9

724

4120

PARO

NOMESCO Finland

5.4

15.8

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.9

15.8

138

B01AC04

ATC

clopidogrel; oral

1.9

15.8

248

1069

WZC30

NOMESCO Finland

Teaching

1.4

15.7

718

4093

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

15.6

264

1166

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.7

15.6

627

6845

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.8

15.6

264

1169

A10BH01

ATC

sitagliptin; oral

1.8

15.5

267

1187

N01

ICPC

Headache

1.3

15.5

1051

6410

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.8

15.5

1399

13673

N05BA02

ATC

chlordiazepoxide; systemic

2.4

15.5

136

457

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

15.5

1568

10123

P72

ICPC

Schizophrenia

2.0

15.4

207

843

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.1

15.4

R4190

NOMESCO Finland

Nutritional therapy

1.8

15.4

254

1113

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.7

15.3

SDC20

NOMESCO Finland

Extensive parodontological fixation

11.6

15.2

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

15.1

524

2820

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

15.1

371

1834

SPE02

NOMESCO Finland

Metal-framed partial denture

3.7

15.1

144

A10BK03

ATC

empagliflozin; oral

1.8

15.1

276

1254

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

15.0

270

1219

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.9

15.0

216

901

D10BA01

ATC

isotretinoin; oral

0.7

15.0

434

5014

P29

ICPC

Psychological sympt/compl other

1.4

15.0

667

3782

H01

ICPC

Ear pain/earache

1.4

14.9

962

5820

RD211

NOMESCO Finland

1.8

14.9

280

1283

K04.62

ICD-10 Finland

Periradicular abscess with fistula to mouth

1.9

14.8

209

869

N05AF05

ATC

zuclopenthixol; systemic

2.8

14.7

282

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

14.7

234

1015

H3603, E103

ICD-10 Finland

2.3

14.7

134

461

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

14.5

1242

7836

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.4

14.5

130

443

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

14.5

358

1775

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.1

14.4

172

669

N05AD01

ATC

haloperidol; systemic

2.0

14.4

183

730

N06AA12

ATC

doxepin; systemic

1.8

14.4

254

1141

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.4

695

4001

SPAT1395

SPAT

Health check-up of persons outside student and working life

2.0

14.3

197

811

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

14.3

498

2684

P76

ICPC

Depressive disorder

1.4

14.3

707

4088

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

14.3

651

3706

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

14.3

417

2158

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.8

14.3

254

1143

KAY20

NOMESCO Finland

0.4

14.3

1212

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

14.3

663

3791

N05AH02

ATC

clozapine; systemic

1.8

14.2

252

1133

SPAT1229

SPAT

Assessment of need for aid

1.7

14.2

311

1493

R95

ICPC

Chron obstructive pulmonary disease

4.2

14.2

105

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

14.1

274

1267

R74

ICPC

Upper respiratory infection acute

1.2

14.1

3294

23241

SPAT1265

SPAT

Breathalyser

2.6

14.0

108

339

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.7

13.9

SPAT1360

SPAT

Extensive global examination

1.5

13.9

431

2263

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

13.9

240

1071

B01AB05

ATC

enoxaparin; parenteral

1.3

13.8

1571

10275

N05AN01

ATC

lithium; oral

1.8

13.8

243

1091

H13

ICPC

Plugged feeling ear

1.4

13.8

791

4691

N03AE01

ATC

clonazepam; systemic

1.6

13.8

393

2022

S01GX01

ATC

cromoglicic acid; ophthalmic

0.8

13.7

1337

12974

N05AB01

ATC

dixyrazine; systemic

3.4

13.7

157

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.9

13.7

198

832

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

13.6

484

2620

Z30.2

ICD-10 Finland

Sterilization

1.3

13.6

1254

7986

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.2

13.6

143

527

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

1.6

13.6

380

1945

SPAT1227

SPAT

Substance abuse rehabilitation

2.8

13.5

251

N06AB06

ATC

sertraline; oral

1.3

13.5

1030

6391

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

13.5

351

1766

R01AD08

ATC

fluticasone; nasal

0.8

13.5

1925

17959

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.1

13.5

151

572

SFA00

NOMESCO Finland

Small filling

1.3

13.4

1256

8013

SPC35

NOMESCO Finland

Production and attachment of single tooth bridge

2.8

13.4

260

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

13.4

1047

6517

T82

ICPC

Obesity

1.6

13.4

361

1832

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

1.7

13.4

257

1186

R11

ICD-10 Finland

Nausea and vomiting

1.5

13.4

552

3082

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.0

13.3

213

SPAT1359

SPAT

Use of symptom diary

2.1

13.3

157

609

TK820

NOMESCO Finland

Peritoneal dialysis

4.8

13.3

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

0.7

13.3

479

5325

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.5

13.2

107

346

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

13.2

476

2585

EKA10

NOMESCO Finland

Biopsy of cheek

2.2

13.2

132

475

SPAT1252

SPAT

Overall medication plan or its review

1.7

13.1

287

1376

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

13.1

550

3082

T84.60

ICD-10 Finland

Gingivitis associated with dental implants

5.6

13.1

L02

ICPC

Back symptom/complaint

1.4

13.1

779

4649

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

3.8

13.0

118

Y6099

ICD-8 Finland

Prenatal care and observation

3.0

13.0

198

C08CA13

ATC

lercanidipine; oral

1.6

13.0

344

1737

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

13.0

2185

14913

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.9

13.0

N04AA02

ATC

biperiden; systemic

2.1

12.9

156

610

Z3226

NOMESCO Finland

Physiotherapist

1.3

12.9

1132

7159

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.8

12.9

213

937

A11

ICPC

Chest pain NOS

1.6

12.9

351

1784

TUPKY

NOMESCO Finland

2.3

12.9

119

412

SPAT1281

SPAT

Other administrative function

1.4

12.9

558

3149

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.6

12.9

293

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

12.8

266

1258

SPAT1058

SPAT

PEF monitoring instruction

1.5

12.8

465

2528

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.8

12.8

221

986

SPF20

NOMESCO Finland

Temporary soling for filling

4.5

12.8

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.9

12.8

194

829

S22.3

ICD-10 Finland

Fracture of rib

1.6

12.7

314

1559

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.7

12.7

587

6277

L01

ICPC

Neck symptom/complaint

1.3

12.7

1110

7021

S29

ICPC

Skin symptom/complaint other

1.3

12.6

1003

6256

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

12.6

541

3046

SPE00

NOMESCO Finland

Fitting and preparation of metal structure partial teeth prosthesis

3.3

12.6

151

SPAT1380

SPAT

Postpartum check-up

0.8

12.6

722

7484

C09BA02

ATC

enalapril and diuretics; systemic

2.0

12.5

170

696

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

12.5

132

488

WX704

NOMESCO Finland

Intubation

1.5

12.5

511

2851

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.7

12.5

269

V03AE01

ATC

polystyrene sulfonate; oral

3.5

12.5

131

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.7

12.5

254

1196

P06

ICPC

Sleep disturbance

1.3

12.5

833

5064

M01AB05

ATC

diclofenac; systemic, rectal

1.2

12.4

5516

40939

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

12.4

417

2231

SBA10

NOMESCO Finland

Measurement of excretion of saliva

2.6

12.4

270

S01

ICPC

Pain/tenderness of skin

1.7

12.4

255

1203

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

12.4

293

1438

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.8

12.3

228

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

2.7

12.3

247

TK810

NOMESCO Finland

Hemofiltration

4.7

12.3

SPAT1059

SPAT

Spirometry at the office

1.7

12.3

269

1292

F61.0

ICD-10 Finland

Mixed personality disorders

1.8

12.3

209

930

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

3.0

12.2

189

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

12.2

199

870

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

3.8

12.2

113

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

12.2

153

609

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

12.2

268

1288

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.2

12.2

125

456

V03AA01

ATC

3.2

12.2

159

S97

ICPC

Chronic ulcer skin

1.9

12.2

187

802

S01.0

ICD-10 Finland

Open wound of scalp

1.6

12.2

349

1800

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

2.4

12.1

106

359

J01AA04

ATC

lymecycline; systemic

0.8

12.1

754

7732

K03.00

ICD-10 Finland

Approximal wear

1.4

12.1

519

2923

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

12.0

241

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

12.0

195

853

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

12.0

155

624

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.7

11.9

424

4727

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

11.9

493

2758

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

2.6

11.9

278

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

11.8

1808

12200

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

11.8

271

1318

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

11.8

792

4817

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

11.8

314

1589

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

11.8

384

2042

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

11.7

340

1760

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

11.7

436

2386

SPAT1379

SPAT

Health check-up of pregnant person

0.8

11.7

915

9121

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.0

11.7

SPAT1211

SPAT

Application of soft bandage

1.4

11.7

503

2835

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.7

284

1405

N03AX09

ATC

lamotrigine; oral

1.4

11.7

537

3064

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.7

11.6

237

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

11.6

436

2388

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.8

11.6

211

960

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1.9

11.6

177

759

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

11.6

1345

8805

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.1

11.6

137

533

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

11.6

188

824

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.6

11.5

115

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.7

11.5

233

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

11.5

385

2061

P74

ICPC

Anxiety disorder/anxiety state

1.5

11.4

428

2345

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

11.4

435

2390

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.6

11.4

324

1666

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1.9

11.4

177

764

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

11.4

555

3202

SPAT1097

SPAT

Recording of ECG

1.4

11.4

623

3667

WW200

NOMESCO Finland

Immunization

1.8

11.3

206

936

Z08

ICPC

Social welfare problem

2.2

11.3

116

423

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.9

11.3

MAE00

NOMESCO Finland

Outlet vacuum delivery

0.7

11.3

345

3945

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

11.3

211

969

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.3

798

4894

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

11.3

903

5637

W90

ICPC

Uncompl labour/delivery livebirth

0.6

11.2

255

3087

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

3.2

11.2

152

RJ411

NOMESCO Finland

3.9

11.2

EB1AA

SPAT

1.5

11.2

402

2185

ECA20

NOMESCO Finland

Biopsy of gingiva

2.8

11.2

215

N05BA12

ATC

alprazolam; oral

1.4

11.2

684

4100

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

11.2

439

2431

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

2.8

11.2

210

SPA50

NOMESCO Finland

Determination of bite and dental arch location

3.4

11.1

123

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

11.1

2564

17987

N06AB05

ATC

paroxetine; oral

1.4

11.1

526

3020

A10BJ06

ATC

semaglutide; parenteral

1.9

11.0

172

745

Z71.8

ICD-10 Finland

Other specified counselling

1.2

11.0

2038

14008

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

11.0

1210

7868

TLOPK

NOMESCO Finland

4.0

11.0

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.4

11.0

484

2742

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

3.5

11.0

116

SPD01

NOMESCO Finland

Mucosa-supported complete denture

4.9

10.9

R51.80

ICD-10 Finland

Headache

1.2

10.9

1376

9091

ZX120

NOMESCO Finland

Intravenous

1.4

10.9

510

2921

KHV

NOMESCO Finland

2.9

10.9

178

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

10.8

219

1031

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

10.8

292

1486

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

10.8

320

1668

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

10.7

405

2224

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

10.7

3109

22215

SPC36

NOMESCO Finland

Direct fibre-reinforced dental bridge

3.8

10.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

10.7

555

3238

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

10.7

517

2978

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

10.7

100

352

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.8

10.7

194

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.3

10.7

346

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

10.7

607

3596

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

10.6

299

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

2.3

10.6

101

356

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.7

10.6

217

1022

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.6

10.6

107

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

1.9

10.6

161

691

P99

ICPC

Psychological disorders other

1.6

10.6

298

1530

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

10.6

281

1425

S21

ICPC

Skin texture symptom/complaint

1.3

10.6

703

4271

A29

ICPC

General symptom/complaint other

1.4

10.6

628

3747

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

10.6

424

2360

C07AG02

ATC

carvedilol; oral

2.1

10.5

123

478

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

10.5

2821

20022

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.2

10.5

104

376

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

10.5

158

676

H05BX01

ATC

cinacalcet; oral

4.6

10.5

Z06

ICPC

Unemployment problem

2.3

10.4

320

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.2

10.4

5AB14

NOMESCO Finland

6.9

10.4

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

10.4

224

1073

N05AA01

ATC

chlorpromazine; systemic, rectal

2.1

10.4

112

418

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

4.7

10.4

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.7

10.4

256

3049

J01AA07

ATC

tetracycline; systemic

0.8

10.4

1097

10584

R60.0

ICD-10 Finland

Localized oedema

1.4

10.4

465

2643

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.3

10.4

126

L05

ICPC

Flank/axilla symptom/complaint

1.6

10.4

306

1590

C03AA03

ATC

hydrochlorothiazide; oral

1.7

10.4

203

948

N06AX03

ATC

mianserin; oral

1.6

10.4

243

1192

A02BA02

ATC

ranitidine; systemic

1.3

10.3

905

5718

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

1.3

10.3

742

4561

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

10.3

2324

16249

N06AB03

ATC

fluoxetine; oral

1.3

10.3

919

5821

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.3

2664

18846

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

10.3

356

1921

M03BX02

ATC

tizanidine; oral

1.2

10.3

5575

41710

N06AX12

ATC

bupropion; oral

1.3

10.2

715

4374

SBB10

NOMESCO Finland

Teeth copy

1.4

10.2

591

3512

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

10.2

340

1819

-1

SPAT

0.6

10.2

116

1644

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.0

10.2

135

551

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

10.2

307

1608

EDB00

NOMESCO Finland

Partial excision of mandible

13.1

10.1

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

10.1

151

644

OAB43

SPAT

0.8

10.1

1734

15971

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

10.1

310

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.8

10.1

983

9563

K04.6

ICD-10 Finland

Periapical abscess with sinus

2.3

10.1

336

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.3

10.0

304

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

10.0

110

417

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

6.2

10.0

SPAT1234

SPAT

Support of social functional capacity

1.6

10.0

239

1179

R07.3

ICD-10 Finland

Other chest pain

1.4

10.0

478

2749

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

10.0

268

1365

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.9

9.9

155

671

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.8

9.9

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

9.9

2968

21235

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1.9

9.9

143

605

C09DA01

ATC

losartan and diuretics; oral

1.6

9.8

282

1458

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

9.8

265

1350

N19

ICD-10 Finland

Unspecified kidney failure

2.5

9.8

234

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

9.8

103

381

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.8

9.8

1625

15013

K02.8

ICD-10 Finland

Other dental caries

1.7

9.7

217

1051

N03AF01

ATC

carbamazepine; oral, rectal

1.6

9.7

262

1333

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.0

9.7

119

472

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

9.7

197

930

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1.9

9.7

148

638

M48.0

ICD-10 Finland

Spinal stenosis

1.6

9.7

265

1353

M05BA04

ATC

alendronic acid; oral

1.8

9.7

172

779

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.7

9.7

207

992

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

9.7

861

5449

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.4

9.7

541

3197

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

9.7

123

495

N17

ICPC

Vertigo/dizziness

1.4

9.7

554

3285

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.4

9.7

L16

ICPC

Ankle symptom/complaint

1.3

9.7

688

4224

M01AH05

ATC

etoricoxib; oral

1.1

9.7

4731

35062

S04

ICPC

Lump/swelling localized

1.3

9.7

638

3874

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

9.7

263

1344

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

9.6

266

1364

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.7

9.6

499

5252

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.0

9.6

146

A97

ICPC

No disease

1.3

9.6

1006

6499

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.4

9.6

SAHTA

NOMESCO Finland

10.1

9.6

ECA10

NOMESCO Finland

Incision of gingiva

2.1

9.6

104

393

SFC00

NOMESCO Finland

Pillar of fillings material

1.7

9.5

190

892

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.5

9.5

289

1513

S15

ICPC

Foreign body in skin

1.5

9.5

319

1710

R52.9

ICD-10 Finland

Pain, unspecified

1.4

9.5

553

3290

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

9.5

349

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2.2

9.5

331

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.5

2351

16549

SDC50

NOMESCO Finland

Strong parodontological fixation of 7 or more teeth

87.8

9.4

H81

ICPC

Excessive ear wax

1.4

9.4

547

3256

N05BE01

ATC

buspirone; oral

1.7

9.4

207

1000

K05

ICD-10 Finland

Gingivitis and periodontal diseases

2.0

9.4

120

483

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

0.8

9.3

700

7022

D01

ICPC

Abdominal pain/cramps general

1.3

9.3

847

5377

ZY010

NOMESCO Finland

Hospital outpatient

1.4

9.3

493

2888

P19

ICPC

Drug abuse

2.0

9.3

118

475

K05.09

ICD-10 Finland

Acute gingivitis, UNS

1.9

9.3

126

519

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.3

354

1951

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.9

9.3

130

542

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

9.3

359

1983

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

9.3

500

2939

8811

FHL

Cesarean section

1.4

9.2

395

2227

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

9.2

597

3613

OAA67

SPAT

0.8

9.2

506

5275

SDPHK

NOMESCO Finland

10.3

9.2

C02AC05

ATC

moxonidine; oral

2.1

9.1

106

413

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.0

9.1

114

456

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.3

9.1

113

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

9.1

324

1761

SPAT1251

SPAT

Organisation of medication

1.7

9.1

182

855

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

2.1

9.1

359

O72.1

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

10919

50050

1.44

179.52

4.4

4.1

mg/mmol

11.4

8.5

5.82

7000

31408

(3019550) Sodium [Moles/volume] in Serum or Plasma

31853

178808

1.90

176.28

19.0

15.2

mmol/l

139.6

139.7

8.73

31184

175137

(3023103) Potassium [Moles/volume] in Serum or Plasma

31918

179298

1.92

176.13

19.2

15.3

mmol/l

4.0

32.83

31192

175384

(3012516) Albumin [Mass/volume] in Urine

10442

47753

1.43

172.03

3.7

3.3

mg/l

371.8

495.5

1.84

6726

30056

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15471

75957

1.39

168.21

7.6

5.9

mmol/l

1.2

0.36

14055

69399

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

25297

135124

1.44

165.67

8.7

7.6

u/l

78.4

76.0

11.85

23894

127964

(3009508) Creatinine [Moles/volume] in Urine

11302

52714

1.41

165.14

3.7

3.3

mmol/l

7.5

7.7

6.05

9467

45168

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16807

84109

1.37

158.85

8.7

6.6

mmol/l

1.2

1.88

14405

70780

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

29061

160325

1.53

150.22

6.5

5.4

mmol/mol

40.3

39.1

70.35

26964

150668

(3032080) INR in Blood by Coagulation assay

13767

67265

1.36

146.90

9.0

8.4

inr

1.2

1.68

3848

20845

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13941

68420

1.36

143.40

2.1

1.9

pmol/l

96.1

97.6

2.93

7214

36389

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

29683

164953

1.54

140.77

15.3

12.3

ml/min/173m2

82.8

84.7

37.80

24732

136904

(3033658) Prothrombin time (PT) actual/Normal

9092

41721

1.40

140.43

4.7

3.9

92.1

92.4

0.36

8847

40612

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17768

90696

1.34

139.79

6.7

6.1

umol/l

10.8

10.9

0.57

16815

86032

(3013826) Glucose [Moles/volume] in Serum or Plasma

19462

101050

1.34

133.67

5.5

4.7

mmol/l

6.8

6.6

16.99

18239

94126

(3024561) Albumin [Mass/volume] in Serum or Plasma

14697

73550

1.33

127.30

5.8

4.9

g/l

35.7

36.0

13.31

13723

68528

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4965

21411

1.44

103.64

8.8

5.9

mmol/l

1.1

1.0

5.90

4663

20108

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5811

25908

1.40

100.46

3.3

2.8

e6/l

3.2

3.0

0.32

3128

14161

(3020779) Urea [Moles/volume] in Serum or Plasma

3415

13815

1.52

97.45

11.3

8.0

mmol/l

9.8

9.2

6.56

3286

13174

(3000991) Gas panel - Venous blood

3132

12461

1.54

96.35

10.9

8.3

—

(3018418) pH of Serum or Plasma

10266

50431

1.30

92.14

5.5

4.1

7.4

0.37

1891

10236

(3030467) Casts [#/volume] in Urine by Automated count

9568

46580

1.31

91.71

3.6

3.1

e6/l

0.4

0.3

1.12

7284

35266

(42870588) Differential panel, method unspecified - Blood

12145

61108

1.28

90.05

6.8

6.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

30105

170355

1.43

89.21

5.0

4.4

mmol/l

6.0

5.8

109.83

27547

158802

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6167

28251

1.36

89.09

3.1

2.7

e6/l

1.0

0.06

3464

16439

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

32630

188093

1.73

85.64

12.4

10.4

u/l

27.2

26.7

3.56

31591

183068

(3002582) Erythrocytes [#/volume] in Urine

10293

51009

1.29

84.56

3.7

3.2

e6/l

74.8

69.1

0.13

7950

39381

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5971

27443

1.36

83.79

3.9

3.5

mmol/l

0.8

9.21

5583

25720

(3021960) Folate [Moles/volume] in Serum or Plasma

8018

38540

1.31

82.55

1.6

1.5

nmol/l

19.9

20.6

4.09

6859

33666

(3020564) Creatinine [Moles/volume] in Serum or Plasma

32528

187501

1.68

81.98

19.1

15.6

umol/l

78.0

75.4

23.92

32523

187412

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9020

44261

1.29

78.74

3.0

ng/l

1398.6

1124.4

4.92

7627

37345

(36304419) Bacteria [Presence] in Urine

9278

45729

1.28

78.09

3.6

3.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4386

19400

1.39

77.27

8.3

7.0

mmol/l

104.3

104.4

0.71

4308

18943

(3023368) Bacteria identified in Blood by Culture

8937

43923

1.28

76.61

4.6

4.3

—

(3044889) 12 lead EKG panel

22123

120722

1.25

76.25

4.0

3.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1863

6937

1.63

75.02

6.9

4.1

mmol/l

24.0

24.2

1.93

1721

6227

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1993

7579

1.60

73.68

10.6

9.6

mmol/l

24.2

24.4

1.81

1879

7099

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9432

46854

1.27

73.54

1.7

mmol/l

1.5

1.4

12.01

8018

39848

(3026250) Tacrolimus [Mass/volume] in Blood

409

854

2.87

73.37

33.9

38.5

ug/l

7.5

0.12

369

793

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8307

40755

1.28

71.13

2.5

2.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3180

13482

1.44

70.55

8.5

6.9

mmol/l

1.3

0.81

3075

13056

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

904

9743

0.54

69.84

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5371

24910

1.33

69.37

2.3

2.1

29.7

29.6

0.87

5229

24122

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4127

18372

1.38

69.33

4.3

4.4

u/l

240.3

237.8

0.54

3883

17432

(3013650) Neutrophils [#/volume] in Blood by Automated count

19068

102867

1.23

69.09

10.6

9.4

e9/l

4.2

4.0

26.08

16719

91285

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3575

15558

1.41

68.56

2.4

2.3

g/l

0.2

0.68

3321

14560

(3042936) Bacteria identified in Isolate by Culture

5374

24981

1.33

68.19

2.2

2.0

—

(3006504) Eosinophils/100 leukocytes in Blood

15887

84179

1.23

67.80

7.1

6.3

2.8

2.9

2.71

14832

78817

(3012544) pH of Venous blood

3342

14400

1.42

67.74

5.7

3.9

7.4

0.26

(3042733) HLA Ab [Presence] in Serum

334

655

3.05

66.64

5.7

4.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

31076

178126

1.42

66.61

5.3

4.7

mmol/l

2.8

28.64

28640

167067

(3022096) Basophils/100 leukocytes in Blood

15398

81428

1.23

66.40

7.2

6.3

0.7

0.28

14397

76257

(3027801) Oxygen [Partial pressure] in Arterial blood

3994

17806

1.38

66.27

8.4

7.3

kpa

12.4

12.6

1.72

3808

17023

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3214

13805

1.42

66.20

5.7

3.9

kpa

5.8

0.69

3123

13416

(3019069) Monocytes/100 leukocytes in Blood

15947

84660

1.22

66.10

7.5

6.6

8.5

8.4

3.19

14951

79743

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3994

17818

1.38

65.97

8.4

7.3

kpa

5.1

1.85

3801

17052

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2902

12268

1.44

65.10

5.7

3.7

ng/l

107.7

87.9

12.64

2541

10636

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10313

52442

1.24

63.45

2.3

2.2

u/l

212.5

197.2

0.69

9674

49452

(3002032) Base excess in Venous blood by calculation

3192

13802

1.41

63.18

5.8

3.9

mmol/l

1.6

1.9

3.26

2656

11343

(3018095) Leukocytes [#/volume] in Urine

11701

60342

1.23

63.10

4.3

3.6

e6/l

71.6

83.4

1.08

8461

42651

(3003396) Base excess in Arterial blood by calculation

3977

17889

1.36

62.12

8.4

7.3

mmol/l

0.9

1.1

3.37

3152

14081

(3044640) Blood type and Crossmatch panel - Blood

10563

54076

1.23

60.26

2.6

2.3

—

(3018010) Neutrophils/100 leukocytes in Blood

16080

85907

1.21

60.17

7.0

6.1

57.3

56.7

8.11

15014

80801

(3015377) Calcium [Moles/volume] in Serum or Plasma

11093

57117

1.23

59.80

3.7

3.3

mmol/l

2.4

4.29

9616

50625

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6619

32162

1.28

59.36

3.9

3.6

ng/l

431.8

422.4

0.07

5069

22770

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3550

15808

1.37

58.82

3.0

2.6

u/l

42.9

39.7

0.27

3043

13550

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

28951

164636

1.30

58.78

5.2

4.9

mu/l

2.0

2.1

0.78

26473

154051

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

323

671

2.88

58.56

3.3

3.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2514

20611

0.70

57.48

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

16249

87153

1.21

57.07

7.2

6.3

27.9

28.7

15.14

15138

81574

(40758558) Short blood count panel - Blood

8776

44239

1.24

57.04

7.6

6.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

24125

134479

1.23

56.83

4.5

4.2

mm/h

12.7

10.9

61.95

22346

126177

(3013115) Eosinophils [#/volume] in Blood

17326

93523

1.21

56.78

7.3

6.4

e9/l

0.2

4.21

15277

83823

(3001604) Monocytes [#/volume] in Blood

16747

90113

1.21

56.71

6.9

6.1

e9/l

0.6

52.74

14538

79471

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2212

9109

1.47

56.50

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

9735

66684

0.81

56.17

3.0

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15624

83572

1.21

56.06

4.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

19888

127343

0.83

55.97

3.0

3.2

—

(3006315) Basophils [#/volume] in Blood

16808

90544

1.20

55.86

6.9

6.1

e9/l

0.0

10.84

14640

79810

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

31006

178302

1.37

55.55

16.5

13.8

mg/l

22.1

21.6

1.52

25445

141232

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5621

26960

1.29

55.36

1.9

—

(3026782) Osmolality of Urine

6730

33025

1.26

55.03

3.2

2.7

mosm/kgh2o

536.4

540.1

0.65

5796

28064

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3939

18013

1.34

54.72

1.9

1.7

—

(3016502) Oxygen saturation in Arterial blood

3578

16128

1.36

54.64

8.8

7.7

95.7

95.9

0.96

3437

15494

(3026493) Urate [Moles/volume] in Serum or Plasma

9068

46075

1.23

54.14

2.9

2.5

umol/l

1683.0

3135.9

5.97

7814

40382

(3026008) Bacteria identified in Urine by Culture

9808

50264

1.22

53.86

3.2

3.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9291

47386

1.23

53.34

4.9

4.7

ug/l

3.2

2.8

0.44

8291

43183

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11112

57743

1.21

52.88

2.9

2.6

u/l

57.5

57.0

0.24

10213

53551

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4855

22997

1.30

52.30

3.4

2.5

22.7

23.2

1.56

4158

19429

(3021589) Normoblasts [#/volume] in Blood

14708

78546

1.20

52.21

10.7

9.7

e9/l

0.0

0.67

12188

65424

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

30585

175741

1.34

51.88

4.8

4.3

mmol/l

4.6

4.7

31.13

28370

165727

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1748

6984

1.51

51.58

1.9

1.7

g/l

1.5

0.82

1519

5965

(3027945) Reticulocytes/100 erythrocytes in Blood

3864

17764

1.33

51.55

2.7

2.6

1.8

1.7

4.48

3409

15861

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

186

292

3.80

51.54

5.7

5.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3931

18142

1.33

51.03

1.9

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

2591

11195

1.41

50.97

4.3

3.2

kpa

4.9

4.6

4.38

2507

10851

(3019309) Folate [Moles/volume] in Red Blood Cells

6300

30935

1.26

50.60

1.8

nmol/l

1111.9

1181.9

7.43

4741

24191

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

30389

174543

1.32

50.52

4.8

4.3

mmol/l

1.4

1.5

57.10

27973

164129

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3304

14994

1.34

47.88

9.4

8.1

g/l

120.9

122.0

2.08

3178

14433

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13846

73906

1.19

47.85

2.5

2.3

nmol/l

75.6

1286.4

0.50

12382

67799

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4269

20094

1.30

47.82

3.1

2.8

umol/l

8.0

7.7

0.35

3642

17290

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11610

61055

1.20

47.13

3.7

3.3

u/l

34.8

32.4

0.79

10972

58066

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1151

4267

1.62

46.88

2.1

2.3

g/l

37.8

38.2

1.34

982

3675

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

456

5351

0.50

46.11

1.5

—

(40768446) Kidney Pathology biopsy report

303

696

2.60

45.82

2.1

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2228

9550

1.41

45.70

10.7

9.2

0.7

3.79

2217

9488

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

417

5014

0.49

45.39

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

2930

13160

1.35

45.31

2.7

e9/l

72.3

69.5

2.35

2142

10221

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5973

29472

1.25

45.30

3.2

2.9

mmol/l

2.5

2.4

17.75

5179

25799

(3019198) Lymphocytes [#/volume] in Blood

17061

92986

1.18

45.26

6.9

6.1

e9/l

2.0

1.9

2.95

15090

83371

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

423

5045

0.49

44.93

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

423

5044

0.49

44.90

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5146

24988

1.26

44.76

3.3

2.4

g/l

2.3

2.4

9.92

4769

23099

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

5032

0.49

44.37

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2230

9622

1.40

44.00

10.7

9.2

93.8

94.0

0.74

2223

9584

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4346

20742

1.28

43.40

4.9

4.3

31.7

32.0

1.21

3002

15525

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5026

24438

1.26

43.05

2.1

1.8

1.6

1.4

27.81

4361

21717

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

29409

168732

1.26

43.00

4.3

3.9

mmol/l

1.4

1.3

71.01

26866

157889

(3047352) Trisomy 18 risk [Likelihood] in Fetus

321

4149

0.45

42.95

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

22083

123260

1.18

42.91

4.9

4.3

—

(3000494) Fungus identified in Specimen by Culture

4606

22172

1.27

42.88

1.6

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2215

9590

1.40

42.81

10.6

9.1

1.4

0.79

2205

9527

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1246

4813

1.56

42.74

3.1

3.3

u/ml

0.3

0.93

656

2850

(3043238) Trisomy 21 risk [Likelihood] in Fetus

337

4261

0.46

42.42

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

618

6458

0.56

42.40

1.4

—

(3005033) Fetal Nuchal fold Thickness US

325

4147

0.46

41.97

1.5

1.4

—

(3024932) HLA-DR beta [Type]

280

649

2.58

41.66

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2628

20421

0.75

41.64

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2032

8715

1.41

41.43

11.3

9.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

5522

27261

1.24

41.20

3.3

2.4

umol/l

13.0

14.4

1.10

5153

25252

(3019225) pH of Specimen

3531

16522

1.30

40.87

4.8

4.2

—

(3024471) HLA-A [Type]

281

661

2.54

40.62

1.0

—

(21494755) Public health laboratory ask at order entry panel

2652

20510

0.75

40.56

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2217

17603

0.73

40.56

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

7165

36444

1.21

39.96

2.9

2.6

e6/l

5.9

5.5

1.52

6323

31803

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4232

20330

1.27

39.81

7.2

7.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

467

5195

0.53

39.80

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1390

11894

0.68

39.58

1.4

—

(4010399)

2840

12971

1.33

39.01

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

33555

196970

1.81

38.68

24.8

20.4

e9/l

254.1

0.05

32753

193272

(3031040) Bacteria [#/volume] in Urine by Automated count

20908

116607

1.17

38.49

4.8

4.4

e6/l

1312.0

1247.7

0.06

238

1670

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2917

13428

1.32

37.87

2.3

2.4

ug/l

7.7

7.0

0.74

2570

11829

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1310

5259

1.50

37.66

2.3

2.4

g/l

10.2

0.04

1087

4317

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1008

3821

1.59

37.48

2.2

2.4

g/l

0.0

0.93

920

3490

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1334

5383

1.49

37.41

2.3

2.4

g/l

3.1

3.0

1.18

1054

4082

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

995

3768

1.59

37.15

2.3

2.4

g/l

0.0

0.00

917

3479

(3026361) Erythrocytes [#/volume] in Blood

33569

197146

1.80

37.00

24.8

20.4

e12/l

4.5

29.27

32653

193055

(3035941) MCH [Entitic mass]

33566

197126

1.80

36.93

24.6

20.3

30.4

30.2

54.38

33155

195289

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1073

4147

1.56

36.71

2.3

2.4

g/l

0.0

0.89

982

3809

(3024731) MCV [Entitic volume]

33566

197135

1.80

36.71

24.7

20.3

91.3

90.7

129.32

33156

195293

(3000963) Hemoglobin [Mass/volume] in Blood

33573

197189

1.80

36.69

24.9

20.5

g/l

135.8

136.2

6.75

33165

195379

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1201

4762

1.52

36.61

2.4

2.5

g/l

0.7

0.9

1.14

1034

4095

(3010813) Leukocytes [#/volume] in Blood

33570

197182

1.79

36.31

24.8

20.5

e9/l

6.9

6.6

107.08

32667

193115

(3010375) cycloSPORINE [Mass/volume] in Blood

314

822

2.28

36.22

26.9

27.5

ug/l

117.2

119.3

0.19

250

664

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1380

5652

1.47

35.94

2.3

2.4

g/l

3.8

0.39

1041

3980

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1382

5664

1.47

35.87

2.3

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1384

5676

1.47

35.80

2.3

2.4

g/l

7.4

7.3

1.20

1074

4187

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1160

4590

1.52

35.70

4.2

3.2

mg/l

1.6

1.5

7.34

1081

4252

(3020630) Protein [Mass/volume] in Serum or Plasma

2793

12899

1.31

35.32

2.5

2.7

g/l

66.5

66.7

0.83

2534

11831

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2150

9580

1.36

34.67

8.6

6.8

mmol/l

24.7

24.8

0.21

2137

9486

(4035726)

3000

14040

1.30

34.35

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1350

5571

1.46

33.83

2.5

2.3

ug/l

394.1

450.0

0.49

1268

5187

(40768804) Tissue Pathology biopsy report

13626

74028

1.16

33.27

2.2

2.1

—

(3024928) Oxygen saturation in Venous blood

857

3224

1.59

32.92

5.1

3.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2333

10607

1.33

32.86

2.3

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5230

26230

1.22

32.73

3.1

2.9

ug/l

0.7

0.09

3510

16741

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

309

3677

0.49

32.63

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1273

10695

0.70

32.57

1.7

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8363

43833

1.18

32.15

2.4

2.3

mg/l

2.8

2.9

0.74

7109

37933

(3007853) Bacteria identified in Skin by Aerobe culture

4399

21714

1.23

32.04

1.9

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

979

3823

1.54

32.01

8.6

6.0

iu/ml

3603.1

1036.5

0.41

213

578

(3013512) EKG study

9096

48047

1.17

31.68

4.1

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4225

20822

1.24

31.16

24.4

22.5

inr

1.3

0.40

550

3228

(40761511) CBC panel - Blood by Automated count

31776

185210

1.29

28.32

15.4

13.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

155

2251

0.41

28.13

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

761

2897

1.57

27.86

3.7

2.7

u/ml

518.2

9928.0

1.31

168

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3615

25805

0.81

27.53

2.0

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1102

4554

1.45

27.42

3.4

3.6

ratio

1.4

3.9

1.20

100

397

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3185

15417

1.25

27.42

4.0

3.9

ug/l

20.0

21.4

0.10

2594

12081

(4146454)

453

1508

1.80

27.35

2.9

2.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2783

13267

1.27

27.28

2.9

2.8

ng/l

176.0

168.4

0.44

2493

12008

(3034860) Kappa light chains.free [Mass/volume] in Serum

1130

4706

1.44

27.00

3.4

3.7

mg/l

45.7

58.9

0.63

916

3744

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1124

4705

1.43

26.14

3.4

3.7

mg/l

43.9

42.3

0.12

905

3746

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5740

39105

0.85

26.09

1.5

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7128

37428

1.17

25.75

4.2

4.1

21.8

21.9

0.22

3171

16972

(3052851) Hemolysis interference index of Serum or Plasma

1180

5001

1.42

25.63

2.8

3.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2226

10406

1.29

25.45

3.8

3.3

kpa

5.1

0.17

2057

9662

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1864

14225

0.77

25.17

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1606

7183

1.35

25.16

3.8

2.9

1.5

1.3

6.09

1598

7142

(3009343) pH of Capillary blood

2194

10278

1.29

24.67

3.7

3.3

7.4

0.10

286

1395

(3004119) Hemoglobin [Mass/volume] in Venous blood

2025

9391

1.30

24.59

4.4

3.4

g/l

127.9

129.8

3.31

1978

9141

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

823

3280

1.50

24.56

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

823

3280

1.50

24.56

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2123

9912

1.29

24.50

3.7

3.3

mmol/l

1.5

1.6

0.66

1569

7316

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11812

64501

1.14

24.12

3.6

3.4

ng/l

61.4

52.2

0.22

7944

40323

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

810

3239

1.50

23.80

1.6

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1454

6467

1.35

23.62

4.0

3.5

mmol/l

24.7

24.8

0.71

1355

6035

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1559

7024

1.33

23.25

3.8

2.9

0.6

0.7

3.12

1511

6747

(3023183) Ammonium ion [Moles/volume] in Plasma

856

3482

1.47

23.14

3.0

2.9

umol/l

35.4

33.5

0.79

741

2949

(3022313) Gas panel - Capillary blood

1618

7349

1.32

22.83

3.9

3.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3309

23392

0.82

22.44

1.9

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

479

4544

0.62

22.41

1.7

1.8

—

(3025315) Body weight

110

3.95

21.60

5.7

4.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

936

3941

1.42

21.14

1.8

1.4

u/ml

21.1

20.2

0.06

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

871

3637

1.43

20.59

1.8

1.5

u/ml

117.6

111.8

0.73

167

937

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2071

9849

1.27

20.57

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1230

5448

1.35

20.55

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

625

2459

1.52

19.90

1.3

u/l

39.6

33.3

0.42

544

2170

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

933

3980

1.40

19.60

1.8

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1477

11253

0.77

19.57

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2870

14236

1.22

19.37

4.4

4.0

0.6

0.7

1.13

655

3106

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

247

2659

0.55

19.01

1.6

1.3

ug/l

2.6

3.3

2.44

205

2353

(3017181) Myelocytes/100 leukocytes in Blood

3105

15556

1.21

18.89

4.5

4.2

0.8

1.0

4.24

882

4251

(44816559) Phosphatidylethanol [Mass/volume] in Blood

862

3687

1.40

17.87

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

7625

41132

1.13

17.59

3.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

854

3663

1.40

17.43

1.4

1.3

u/ml

290.2

268.8

1.11

582

2417

(3036489) Thrombin time

1383

6393

1.30

17.20

2.2

2.1

21.5

21.2

0.97

1215

5399

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

346

1224

1.69

17.14

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

707

2941

1.44

17.13

6.0

5.4

umol/l

376.9

368.8

0.77

621

2584

(3020191) Ethanol [Moles/volume] in Serum or Plasma

421

1569

1.60

17.05

1.5

promille

1.5

1.4

1.04

323

1211

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1136

5119

1.33

16.97

3.0

2.6

g/l

3.6

0.34

1094

4866

(3017143) Hepatitis C virus Ab [Presence] in Serum

4528

23625

1.16

16.94

1.9

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4783

32103

0.87

16.83

1.5

—

(3025159) Blasts/100 leukocytes in Blood

2796

14024

1.20

16.74

4.6

4.3

0.1

0.3

2.16

702

3354

(3049717) Cytology report of Urine Cyto stain

1252

5734

1.31

16.69

2.7

2.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1189

5419

1.32

16.42

2.4

2.2

90.8

93.5

3.33

1118

4986

(3021440) Promyelocytes/100 leukocytes in Blood

2928

14778

1.19

16.37

4.6

4.3

0.1

1.78

817

3938

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7449

40282

1.13

16.30

1.9

1.8

mg/l

1.2

1.1

2.49

5669

30168

(3029634) Reagin Ab [Titer] in Serum by VDRL

659

2737

1.44

16.14

2.5

2.1

titre

5.1

6.6

0.26

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

890

3903

1.36

15.92

1.4

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.85

15.87

12.2

7.9

e6/l

185.5

394.9

0.48

(40760888) Immunoglobulin light chains.free panel - Serum

843

3670

1.37

15.78

3.4

3.7

—

(3019060) Gas panel - Arterial blood

2197

10826

1.22

15.78

5.3

5.1

—

(3045716) Anion gap in Serum or Plasma

223

712

1.87

15.62

3.1

2.3

mmol/l

9.5

8.9

0.91

169

495

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

385

1448

1.59

15.08

4.1

3.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

640

5281

0.71

14.74

1.8

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1072

4893

1.31

14.68

2.8

2.6

195.0

181.5

4.63

1024

4613

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1011

4579

1.32

14.63

1.6

1.5

iu/ml

18.1

16.9

0.08

108

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

759

3290

1.38

14.62

3.5

2.2

nmol/l

0.9

0.8

1.97

596

2799

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

857

3795

1.35

14.45

2.4

2.5

ug/min

163.2

123.4

1.09

475

2270

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1120

5155

1.30

14.44

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2545

12840

1.19

14.25

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

476

1902

1.49

14.24

1.1

—

(40768797) Stomach Pathology biopsy report

4815

25521

1.14

14.24

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

25731

148883

1.11

14.14

20.7

16.3

13.7

13.6

24.66

25282

146029

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.77

14.06

3.8

3.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

558

2308

1.44

14.03

6.3

6.4

mg/l

11.4

11.3

0.02

511

2124

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

232

777

1.78

14.02

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

520

2125

1.46

13.93

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

21766

124947

1.10

13.83

3.7

3.1

u/l

52.2

45.5

17.62

20304

118176

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1429

6819

1.26

13.81

5.8

5.2

1.8

1.7

2.40

1330

6388

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

755

3315

1.36

13.47

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

235

800

1.75

13.47

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

474

1917

1.48

13.40

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

415

1640

1.51

13.13

1.9

1.8

ug/l

26.4

20.8

1.01

402

1612

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

323

1206

1.60

13.12

1.5

—

(3051651) Icteric interference index of Serum or Plasma

243

842

1.72

13.11

3.2

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

24528

141749

1.10

13.05

4.3

4.2

pmol/l

14.7

6.52

22259

131245

(3041806) Other cells [#/volume] in Blood by Manual count

686

0.29

12.72

1.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1400

6738

1.25

12.58

5.8

5.3

0.9

2.42

1300

6318

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

137

2.87

12.39

2.8

2.6

mg/l

2.5

2.2

0.62

123

(3002256) Pathology report gross observation

4297

22806

1.14

12.33

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

642

2788

1.38

12.31

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

458

1873

1.46

12.29

1.2

u/l

62.4

62.1

0.02

314

1275

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

867

6631

0.77

11.89

1.5

—

(4034850)

720

5629

0.76

11.66

12.2

9.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

625

2728

1.37

11.64

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

408

3485

0.69

11.60

1.1

u/ml

2.7

1.8

0.51

110

847

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

535

2277

1.40

11.59

2.4

2.5

—

(3003181) Sodium [Moles/volume] in Urine

626

2736

1.37

11.57

1.4

mmol/l

64.2

62.6

0.35

488

2154

(3014148) Varicella zoster virus Ab [Titer] in Serum

603

2621

1.37

11.53

1.1

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2844

14737

1.16

11.46

2.8

2.7

ml/min/173m2

65.9

67.8

1.15

1108

5747

(3000475) Leukocytes [#/volume] in Synovial fluid

939

4364

1.29

11.33

1.6

1.7

e6/l

10856.4

13085.8

0.76

658

3242

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

618

2708

1.36

11.25

1.1

iu/ml

60.5

972.2

1.07

144

648

(3003434) Protein [Mass/volume] in Pleural fluid

418

1711

1.46

11.21

1.4

1.5

g/l

33.2

32.8

0.19

375

1572

(3051387) C reactive protein [Mass/volume] in Capillary blood

489

4022

0.72

11.15

3.9

3.5

mg/l

25.3

24.7

0.10

287

2365

(40768443) Skin Pathology biopsy report

1572

7760

1.21

11.12

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

343

2998

0.68

11.07

1.0

1.1

u/ml

4.4

3.7

0.34

146

1174

(3023323) Follitropin [Units/volume] in Serum or Plasma

1627

11512

0.83

10.88

1.4

1.3

iu/l

32.2

27.9

5.39

1371

10009

(3037756) Immunofixation for Serum or Plasma

707

3182

1.33

10.81

1.7

1.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

265

992

1.59

10.75

1.3

u/l

23.9

25.3

0.16

228

862

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

271

1022

1.58

10.67

1.3

u/l

90.3

92.1

0.10

238

901

(3012441) Differential panel - Pleural fluid

331

1307

1.51

10.63

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

383

1559

1.47

10.60

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

419

1738

1.44

10.52

3.4

58.5

57.3

0.42

282

1129

(3017569) Oxygen content in Arterial blood

190

658

1.72

10.39

2.1

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

372

1515

1.46

10.29

2.9

3.0

mg/l

77.0

45.1

0.84

263

1070

(3037121) Protein [Mass/volume] in Urine

1216

5897

1.23

10.25

3.3

3.2

g/l

0.4

0.3

2.48

567

2444

(3044941) Cell count panel - Synovial fluid

627

2805

1.33

10.03

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1091

5251

1.24

9.88

3.7

3.3

u/ml

1192.7

2089.1

0.29

916

4468

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2850

14929

1.15

9.87

1.6

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

338

1365

1.48

9.78

1.5

e6/l

56174.3

61274.7

0.11

188

821

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1514

7558

1.20

9.56

1.7

1.6

u/ml

14.3

15.0

0.08

206

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2728

14279

1.15

9.55

4.4

4.0

mmol/l

1.2

0.68

2444

12468

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

976

4658

1.25

9.54

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

369

1525

1.44

9.50

1.5

e6/l

5023.6

3200.3

0.43

247

1148

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

1359

0.56

9.47

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2122

10912

1.17

9.46

1.8

1.9

g/l

1.3

0.33

1934

10003

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1233

6042

1.22

9.44

1.6

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

332

2823

0.70

9.30

1.0

1.1

u/ml

4.4

3.7

0.32

146

1171

(40768806) Pleura Pathology biopsy report

320

1297

1.47

9.13

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1488

7452

1.20

9.09

4.0

3.5

mmol/l

25.1

25.3

1.95

1434

7216

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

253

980

1.54

8.96

1.3

titre

62.6

76.7

0.29

(3027923) C peptide [Moles/volume] in Serum or Plasma

252

981

1.53

8.74

1.5

1.6

nmol/l

1.3

1.2

0.64

199

782

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

532

4155

0.76

8.67

1.1

u/ml

2.0

1.4

0.68

225

1657

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

864

4114

1.25

8.66

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

244

946

1.54

8.63

1.9

1.6

iu/ml

606059.4

2570170.8

3.61

(3034770) Mitochondria Ab [Titer] in Serum

1071

5226

1.23

8.58

1.2

titre

681.2

1000.6

0.96

147

(40768800) Prostate Pathology biopsy report

540

2422

1.33

8.57

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2683

14137

1.14

8.52

2.8

2.7

g/l

10.5

0.11

2484

12942

(3021788) Differential panel - Synovial fluid

718

3354

1.28

8.45

1.6

1.5

—

(3045788) Cell count panel - Pleural fluid

287

1159

1.48

8.39

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.37

8.35

3.6

3.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

1084

5313

1.22

8.33

1.2

titre

115.6

112.6

0.05

502

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

760

3586

1.27

8.25

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

316

1305

1.44

8.24

2.9

2.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

255

1009

1.51

8.23

1.4

1.3

titre

444.2

421.1

0.03

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2031

10525

1.16

8.20

7.8

7.3

mmol/l

24.5

24.6

0.69

1885

9805

(3000492) Spirometry study

3451

18524

1.12

8.09

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

278

2374

0.69

8.05

1.0

u/ml

0.3

0.5

0.62

497

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

296

1216

1.45

7.96

1.3

u/l

599.2

484.8

0.39

276

1157

(3023487) Leukocytes [#/volume] in Peritoneal fluid

138

473

1.74

7.95

2.3

2.2

e6/l

359.4

3708.3

1.12

336

(3004775) Volume in Urine collected for unspecified duration

278

1130

1.47

7.90

2.4

2.2

748.1

705.0

0.79

180

781

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

365

1560

1.39

7.89

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

402

3221

0.74

7.89

1.4

nmol/l

0.4

0.13

290

2502

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

215

828

1.55

7.88

2.0

1.9

umol/l

175.7

121.6

1.06

100

418

(3002523) Influenza virus A Ag [Presence] in Specimen

389

3126

0.74

7.79

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

389

3126

0.74

7.79

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

250

2.02

7.78

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1340

6758

1.19

7.62

4.6

3.9

49.1

49.3

0.10

1322

6692

(3005082) Progesterone [Moles/volume] in Serum or Plasma

102

1075

0.56

7.61

1.4

nmol/l

26.1

31.6

1.32

971

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1182

8325

0.84

7.58

2.2

u/l

5911.9

5763.9

0.05

394

3208

(3044007) Cell count panel - Peritoneal fluid

111

364

1.82

7.44

2.4

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

498

2257

1.32

7.42

3.0

2.7

u/ml

114.1

780.9

0.89

483

2159

(3048929) Epstein Barr virus Ab [Presence] in Serum

1218

6113

1.19

7.34

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

543

2495

1.30

7.32

3.1

3.2

nmol/l

0.8

1.92

421

1912

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

293

1222

1.43

7.31

2.0

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1282

6468

1.19

7.28

2.1

ug/l

2.7

1.8

1.13

1129

5745

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

361

1564

1.38

7.25

1.3

1.4

nmol/l

1.4

0.52

319

1418

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1316

6663

1.18

7.17

1.9

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

317

1348

1.40

7.11

13.2

12.5

mmol/l

0.6

0.80

285

1251

(3011985) Renin [Units/volume] in Plasma

521

2391

1.30

7.11

1.5

1.6

mu/l

71.4

60.5

0.69

469

2134

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

796

5775

0.81

7.03

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

367

1603

1.36

7.02

3.0

3.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

938

6697

0.83

7.02

1.8

1.7

mg/l

6.1

3.5

3.09

732

4722

(44806420)

312

1.85

6.94

2.3

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

132

1270

0.62

6.92

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

484

2212

1.30

6.83

1.3

1.4

pmol/l

277.5

306.1

1.18

387

1742

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

101

331

1.82

6.82

4.1

6.4

64.5

70.3

1.08

265

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

120

416

1.72

6.73

10.7

8.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

482

3680

0.78

6.71

1.1

u/ml

3.8

5.3

1.64

254

1893

(40761536) Microorganisms panel - Urine sediment

2479

16406

0.89

6.67

4.6

3.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1202

6081

1.18

6.64

1.7

1.6

iu/ml

0.6

7.2

1.23

228

1202

(3045142) Bone marrow Pathology biopsy report

383

1700

1.34

6.64

1.3

—

(3042517) Benzodiazepines panel - Urine

292

1.85

6.58

3.5

3.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

971

4827

1.20

6.55

1.5

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

189

1662

0.67

6.52

1.5

1.6

mmol/l

8.4

7.6

2.04

1002

(3016650) Hepatitis A virus Ab [Presence] in Serum

665

3182

1.25

6.51

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

168

641

1.56

6.50

1.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

356

1570

1.35

6.45

19.8

18.6

nmol/l

1450.7

3482.9

1.00

346

1507

(40760892) CBC W Ordered Manual Differential panel - Blood

6728

42441

0.93

6.43

5.2

4.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1094

5508

1.19

6.41

1.5

1.4

ug/g

264.4

281.6

1.82

646

3147

(3008757) Leukocyte morphology finding [Identifier] in Blood

420

1902

1.32

6.37

3.8

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1127

7847

0.85

6.36

1.7

1.6

mu/l

304.2

306.0

0.05

1011

7078

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

545

2555

1.27

6.36

1.3

nmol/l

0.2

0.16

143

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1424

7332

1.16

6.34

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

263

1107

1.42

6.31

1.6

u/l

6.0

0.01

122

528

(3008401) Mugwort IgE Ab [Units/volume] in Serum

457

3480

0.78

6.27

1.1

u/ml

1.3

1.1

0.19

205

1460

(3026389) Candida sp identified in Specimen by Organism specific culture

667

3208

1.24

6.25

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

426

1.68

6.21

2.2

2.1

e6/l

2221.2

9107.3

2.21

245

(3016038) Potassium [Moles/volume] in Urine

246

1027

1.43

6.19

1.2

mmol/l

30.2

33.8

1.66

204

879

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

339

1496

1.35

6.14

14.1

13.2

nmol/l

798.0

1505.5

0.54

332

1441

(3009542) Hematocrit [Volume Fraction] of Blood

27807

162959

1.08

6.14

18.6

14.3

40.2

40.1

0.96

19870

121354

(3003338) MCHC [Mass/volume]

25208

152382

0.94

6.13

22.2

17.4

g/l

332.4

332.9

16.91

25064

151428

(3038071) Oxygen [Partial pressure] in Mixed venous blood

107

371

1.72

6.04

11.3

8.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

494

2306

1.28

5.99

1.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

283

1220

1.38

5.95

3.1

2.8

ug/l

24.2

24.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

543

2569

1.26

5.91

1.3

nmol/l

0.6

1.5

0.91

519

2475

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

345

1537

1.34

5.89

1.2

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

595

2846

1.25

5.89

3.4

3.3

1.2

1.4

1.08

447

2232

(3028707) Methadone [Presence] in Urine by Screen method

783

3857

1.21

5.86

3.8

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

6015

37979

0.93

5.83

2.0

1.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

158

611

1.54

5.82

6.6

6.2

mmol/l

25.2

0.03

146

564

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11322

70011

0.94

5.82

4.1

3.8

—

(3033799) Differential panel - Peritoneal fluid

117

421

1.65

5.79

1.8

2.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

532

2522

1.26

5.71

1.1

g/l

1.5

0.76

473

2294

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

225

940

1.43

5.68

6.9

6.1

u/ml

238.6

1217.6

0.78

187

(4198724)

238

1005

1.41

5.67

2.5

2.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

489

2299

1.27

5.63

1.2

1.1

iu/ml

1.6

2.2

0.52

(3008295) Osmolality of Serum or Plasma

376

1714

1.31

5.51

1.4

1.5

mosm/kgh2o

280.7

279.4

0.46

286

1380

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1536

8048

1.14

5.40

1.1

u/ml

3.5

6.9

0.53

128

(3047007) Chlamydophila sp Ab [Presence] in Serum

389

2961

0.78

5.39

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

1638

8622

1.14

5.37

2.0

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

641

3127

1.22

5.33

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

381

2902

0.78

5.31

1.1

u/ml

3.8

2.7

0.83

158

1415

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2095

13813

0.90

5.31

1.2

iu/ml

147.6

133.4

0.85

709

5334

(3020876) Protein [Mass/time] in 24 hour Urine

320

1434

1.33

5.31

1.8

2.1

g/24h

1.3

1.0

0.24

(3008116) Ketones [Moles/volume] in Urine by Test strip

102

363

1.67

5.30

1.6

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3203

17506

1.10

5.30

2.3

2.2

nmol/l

361.9

369.1

1.16

2917

16181

(3002331) Protein [Mass/volume] in Peritoneal fluid

305

1.74

5.29

1.4

g/l

26.3

42.7

0.43

246

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1173

6041

1.16

5.27

1.6

1.7

titre

266.0

266.6

0.00

286

(3006184) Hemoglobin [Mass/volume] in Capillary blood

805

4023

1.19

5.22

2.3

2.2

g/l

130.6

131.4

0.37

576

2980

(3003694) ABO and Rh group [Type] in Blood

8755

49725

1.06

5.20

1.4

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

353

1609

1.31

5.20

2.0

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

639

3126

1.22

5.18

3.2

3.4

u/ml

716.2

529.8

0.26

578

2832

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

699

1.46

5.07

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1106

5689

1.16

5.07

4.4

4.3

mmol/l

1.4

1.3

1.25

1086

5590

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

700

1.46

5.04

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

489

2332

1.25

5.04

2.0

1.8

titre

2009.2

3870.4

0.82

100

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

847

4267

1.18

5.03

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

196

820

1.42

4.97

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

646

3178

1.21

4.97

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

621

0.54

4.96

1.0

—

(3009261) Glucose [Presence] in Urine by Test strip

15587

90055

1.05

4.95

3.9

3.7

estimate

0.0

0.02

3072

17371

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

196

821

1.42

4.94

1.4

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.91

4.83

21.7

17.9

—

(36660697) Celiac disease serology panel - Serum

2907

15888

1.10

4.82

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

269

1194

1.34

4.80

1.6

1.5

u/ml

21.4

24.1

0.34

230

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6582

37144

1.07

4.75

1.7

pmol/l

62479589.5

30892152.9

2.46

5397

31400

(3032868) Hemoglobin electrophoresis panel in Blood

139

2.05

4.74

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

351

2659

0.78

4.73

1.9

2.0

umol/l

7.9

7.1

0.24

250

1948

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

315

1434

1.31

4.73

1.2

titre

133.7

180.2

0.51

252

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

314

1429

1.31

4.73

1.2

titre

156.4

183.5

0.08

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

249

1096

1.35

4.71

1.4

1.5

—

(40768441) Liver Pathology biopsy report

277

1241

1.33

4.66

1.7

1.4

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.91

4.63

7.6

10.7

52.7

42.7

0.70

(3042111) Morphology [Interpretation] in Bone marrow Narrative

542

2641

1.22

4.62

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1749

9335

1.12

4.61

2.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

131

1149

0.68

4.61

2.2

1.7

—

(3047181) Lactate [Moles/volume] in Blood

1111

5768

1.15

4.53

6.6

5.9

mmol/l

1.3

0.02

977

5124

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

174

726

1.43

4.53

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

602

4286

0.83

4.53

1.4

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

15390

89018

1.05

4.52

3.9

3.6

estimate

0.0

1.46

3093

17455

(3039000) Anion gap in Blood

800

4051

1.18

4.52

7.7

6.9

mmol/l

11.2

11.1

0.28

714

3667

(3018572) Chloride [Moles/volume] in Blood

800

4052

1.18

4.50

7.7

6.9

mmol/l

105.0

105.1

0.31

714

3669

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

762

5313

0.85

4.50

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

527

1.50

4.49

1.6

1.5

—

(3006462) Nitrate [Presence] in Urine

206

887

1.38

4.48

3.9

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

244

1083

1.34

4.40

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

334

1549

1.28

4.40

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.37

4.28

2.3

5.4

—

(21494434) Karyotype in Bone marrow

291

1331

1.30

4.27

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

816

4160

1.17

4.27

3.0

2.9

mmol/l

24.4

24.5

0.31

723

3661

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

100

377

1.58

4.24

1.1

—

(40761535) Cells panel - Urine sediment

2635

14431

1.09

4.20

3.7

3.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

279

1275

1.30

4.14

1.3

mmol/l

6.3

6.2

0.25

254

1195

(4211845)

224

992

1.34

4.13

3.7

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

199

1589

0.74

4.05

1.2

1.3

u/ml

1.6

1.0

0.25

102

693

(3042631) Mycobacterium sp identified in Specimen

469

2286

1.22

4.05

2.4

2.7

—

(3048879) Bone marrow aspiration report

119

473

1.50

4.01

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

482

2359

1.22

4.00

1.9

2.2

mg/l

26.7

26.8

0.01

154

683

(3044242) Glucose [Moles/volume] in Arterial blood

168

714

1.40

4.00

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

273

1252

1.30

3.96

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

459

2238

1.22

3.96

1.6

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

421

3057

0.82

3.95

1.1

au/ml

17.7

12.3

0.32

187

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

274

1258

1.30

3.95

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

505

2487

1.21

3.94

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3879

21635

1.07

3.94

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

252

0.38

3.92

5.9

5.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6121

34658

1.06

3.92

1.3

iu/ml

36.4

32.0

0.93

1864

10823

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

367

1749

1.25

3.91

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

174

748

1.38

3.89

2.1

2.2

ug/min

150.2

86.5

0.59

169

(3041096) Erythrocytes [Presence] in Urine by Automated

8012

49574

0.95

3.88

3.6

3.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

294

1366

1.28

3.87

1.1

—

(3015183) Erythrocyte sedimentation rate

123

1053

0.69

3.87

1.4

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

406

2951

0.82

3.86

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.90

3.83

5.7

6.0

mg/l

1.5

0.02

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.58

3.80

7.6

10.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

516

2558

1.20

3.78

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1460

9622

0.90

3.76

1.1

titre

258.8

191.1

0.46

218

(3017732) Neutrophils [#/volume] in Blood

2475

13592

1.09

3.74

3.0

2.8

e9/l

4.3

4.0

6.02

1886

11030

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5793

32801

1.06

3.70

1.3

u/ml

13.7

10.1

2.65

2037

12976

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

406

1971

1.23

3.68

1.1

96.3

96.1

0.03

381

1848

(3025468) Yersinia sp identified in Specimen by Organism specific culture

495

2452

1.20

3.67

1.5

—

(3022689) Creatine [Moles/volume] in Urine

113

454

1.48

3.66

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

495

2453

1.20

3.65

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

648

0.62

3.65

1.0

1.1

u/ml

11.3

9.6

0.18

(3029396) Erythrocyte agglutination [Presence] in Blood

559

0.59

3.65

2.4

3.0

—

(3012898) Urea [Moles/volume] in Urine

176

1.79

3.63

1.3

1.5

mmol/l

147.0

166.5

0.51

157

(3005988) Vibrio sp identified in Specimen by Organism specific culture

495

2456

1.20

3.61

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

613

3100

1.18

3.61

3.7

3.1

mmol/l

1.5

0.04

601

3022

(3028626) Oxygen [Partial pressure] in Capillary blood

701

3586

1.17

3.58

3.4

2.7

kpa

8.4

0.19

651

3329

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

402

2896

0.82

3.53

1.6

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

302

1427

1.26

3.51

1.1

mg/l

292.8

495.8

0.49

263

1285

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

560

2820

1.18

3.48

1.2

u/ml

3.4

3.7

0.24

241

1257

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

192

1.73

3.46

1.1

1.2

mmol/l

—

2.4

—

(3017704) Immunofixation for Urine

202

908

1.32

3.45

1.8

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

394

1924

1.22

3.41

1.8

—

(3022145) Colonoscopy Study observation

3673

20555

1.07

3.40

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

180

1.75

3.39

1.2

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

499

2494

1.19

3.39

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

215

979

1.31

3.36

1.3

u/l

13.2

15.2

0.61

196

899

(3014599) Egg white IgE Ab [Units/volume] in Serum

149

1203

0.74

3.35

1.0

u/ml

0.4

2.2

1.48

286

(3020874) Milk IgE Ab [Units/volume] in Serum

155

1244

0.74

3.35

1.0

u/ml

0.4

1.8

1.31

340

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.74

3.34

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

198

892

1.32

3.34

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

233

1074

1.29

3.33

1.6

1.8

—

(3008898) HLA-B27 [Presence]

1121

7440

0.89

3.32

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

363

1.51

3.29

1.2

1.3

ug/l

505.1

300.2

0.32

190

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

475

2374

1.19

3.25

1.5

1.4

—

(3047189) Immunofixation for 24 hour Urine

153

666

1.37

3.24

1.7

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

819

4272

1.14

3.24

1.5

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

661

3398

1.16

3.21

4.3

3.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

193

873

1.32

3.19

1.1

iu/ml

3.3

4.1

0.55

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

195

1503

0.77

3.17

1.3

1.4

pmol/l

96.7

141.7

0.40

531

(3026692) Albumin [Mass/volume] in Peritoneal fluid

357

1.50

3.15

1.3

1.6

g/l

13.1

13.6

0.22

271

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

675

0.66

3.15

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

152

665

1.36

3.14

2.1

1.6

u/ml

19580.6

28409.7

0.13

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

206

943

1.30

3.13

1.1

u/l

79.5

86.9

0.73

154

758

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

119

501

1.41

3.09

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

344

2476

0.82

3.05

1.2

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

937

4952

1.13

3.05

4.7

4.5

mmol/l

3.9

0.05

892

4639

(4281824)

340

1657

1.22

3.05

1.1

1.2

—

(3034426) Prothrombin time (PT)

142

618

1.37

3.04

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

108

1.93

3.04

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

819

4294

1.14

3.03

1.8

1.7

—

(4306422)

562

2868

1.17

3.03

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

760

3965

1.14

3.03

1.2

u/ml

7.5

18.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

15349

89284

1.04

3.02

5.2

4.8

estimate

0.0

3.74

3164

17903

(21491868) Cryoglobulin [Mass/volume] in Serum

140

609

1.37

3.01

1.3

1.2

g/l

0.4

0.8

0.65

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

109

907

0.71

3.01

2.8

2.3

ug/l

19.9

218.6

1.09

102

867

(3015076) Soybean IgE Ab [Units/volume] in Serum

134

1078

0.74

2.99

1.0

u/ml

0.5

0.9

0.31

146

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

174

1.71

2.99

1.3

1.2

mg/l

42.9

48.1

0.45

(3013139) Helicobacter pylori Ag [Presence] in Stool

2367

13105

1.08

2.98

1.3

1.2

—

(4212803)

126

1.84

2.97

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

4768

27029

1.06

2.92

1.4

titre

529.1

538.4

0.12

1003

5393

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

327

1597

1.22

2.90

3.4

2.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

790

4149

1.13

2.87

1.9

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

140

1109

0.75

2.83

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

204

947

1.28

2.83

1.1

u/l

18.9

25.3

1.27

150

718

(3009871) Measles virus Ab [Titer] in Serum

163

734

1.32

2.82

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

480

2435

1.17

2.82

1.6

57.5

55.0

0.66

309

1505

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

101

422

1.42

2.77

1.1

1.2

pmol/l

312.7

327.5

0.11

318

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.98

2.74

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

2051

13099

0.93

2.74

1.3

u/ml

271.1

225.4

0.78

1879

12177

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.27

2.70

2.8

—

(1616796) Gas panel - Central venous blood

756

3979

1.13

2.68

4.0

3.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

108

880

0.73

2.67

1.6

1.7

—

(44806118)

398

2002

1.18

2.61

1.8

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

6525

37385

1.05

2.61

1.5

g/l

2.5

2.3

7.13

3707

23274

(44790049)

398

2003

1.18

2.60

1.8

1.6

—

(44790048)

398

2004

1.18

2.59

1.8

1.6

—

(44790047)

398

2004

1.18

2.59

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

159

724

1.31

2.58

2.2

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

549

2836

1.15

2.58

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

185

860

1.28

2.57

1.8

1.5

nmol/l

5.5

9.3

0.26

161

707

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2453

13685

1.07

2.55

2.3

nmol/l

12.4

12.5

0.39

2133

12255

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

384

1931

1.18

2.54

1.9

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

129

1.75

2.52

1.1

u/l

22.4

20.0

0.17

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

157

717

1.30

2.51

2.2

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

157

717

1.30

2.51

2.2

2.3

—

(3019150) Specific gravity of Urine by Refractometry

6539

40263

0.96

2.49

4.1

kg/l

1.0

1.70

907

6173

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

260

1.51

2.47

1.1

pmol/l

3.9

3.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

336

1675

1.19

2.47

2.6

2.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

205

971

1.26

2.46

1.3

1.5

umol/l

20.3

24.2

1.23

190

926

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

581

3026

1.14

2.45

1.9

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

616

3221

1.14

2.45

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

199

940

1.26

2.45

2.0

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

266

1.50

2.42

2.3

2.0

—

(3021901) Oxygen saturation in Capillary blood

576

3002

1.14

2.41

3.1

2.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

536

2780

1.15

2.41

1.1

119.1

0.00

489

2524

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

198

937

1.26

2.41

2.0

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

198

937

1.26

2.41

2.0

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

198

937

1.26

2.41

2.0

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3130

17636

1.06

2.40

3.6

3.3

—

(3002619) Bacteria identified in Specimen by Culture

375

1.41

2.39

1.2

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

380

1.41

2.39

1.3

mu/l

127.2

70.9

0.33

282

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1280

8275

0.92

2.35

1.3

1.2

u/ml

0.8

0.9

0.07

717

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

322

1.44

2.34

1.3

1.4

ng/l

63.5

338.1

0.51

198

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

352

1.42

2.33

2.9

2.6

—

(3003129) Base excess in Capillary blood by calculation

422

1.38

2.33

1.5

1.6

mmol/l

-0.0

0.5

0.68

398

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

128

1.72

2.33

2.0

2.3

69.4

54.6

1.41

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

106

1.80

2.32

2.0

1.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

511

0.67

2.29

3.5

3.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

403

2056

1.17

2.28

1.7

1.5

iu/ml

33.6

32.0

0.07

101

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

510

0.68

2.27

7.0

6.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

625

1.30

2.25

1.7

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

107

471

1.35

2.24

1.3

1.4

59.3

62.3

0.36

394

(3023419) Bacteria identified in Sputum by Culture

428

2201

1.16

2.20

2.3

2.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

224

1.51

2.19

7.2

7.6

—

(3038026) Centromere Ab [Units/volume] in Serum

311

1559

1.19

2.19

1.2

u/ml

49.0

52.4

0.05

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

426

2916

0.87

2.18

1.3

1.4

mmol/l

7.3

7.0

1.01

299

2053

(3038515) Glucose [Moles/volume] in Venous blood

554

2905

1.14

2.16

3.8

3.2

mmol/l

7.5

7.4

0.37

545

2838

(3022493) Free Hemoglobin [Mass/volume] in Plasma

161

756

1.27

2.13

7.6

5.4

mg/l

1278.7

2534.3

0.41

127

528

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

352

0.62

2.13

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

125

568

1.31

2.13

1.7

1.6

ug/l

9.4

9.0

0.40

125

568

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.01

2.12

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

206

996

1.23

2.12

1.0

ng/l

275.7

356.7

1.35

149

719

(3006653) Thiamine [Moles/volume] in Blood

207

1002

1.23

2.11

1.3

1.4

nmol/l

135.1

138.6

0.59

207

1002

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

743

0.74

2.10

1.2

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

335

0.62

2.08

1.1

—

(3035880) pH of Pleural fluid

154

723

1.27

2.06

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

557

2933

1.13

2.05

1.2

u/ml

3.4

3.1

0.19

198

991

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1127

7276

0.92

2.05

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.98

2.05

11.1

8.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

207

1006

1.22

2.04

1.0

ng/l

37.4

44.4

1.42

142

717

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

102

1.75

2.03

1.9

2.3

9.7

16.6

0.85

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

317

1.41

2.03

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

205

0.52

2.03

2.1

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1293

7113

1.08

2.02

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

189

913

1.23

1.98

2.0

umol/l

32.5

25.3

0.18

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

264

1.44

1.98

1.9

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

121

1.67

1.98

5.4

5.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

206

1005

1.22

1.97

1.0

ng/l

759.4

764.1

0.05

144

702

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

905

5888

0.91

1.97

1.1

u/ml

9.5

5.1

0.69

753

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

754

4054

1.11

1.95

1.2

u/ml

7.7

5.1

0.27

303

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

306

1551

1.17

1.94

1.7

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

306

1551

1.17

1.94

1.7

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

306

1551

1.17

1.94

1.7

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

497

2613

1.13

1.91

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

118

1.66

1.90

1.7

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

105

1.70

1.87

1.1

1.0

u/l

60.0

50.5

0.25

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

156

1.56

1.86

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

313

1.39

1.85

8.4

7.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

185

1.51

1.84

1.4

1.3

—

(3007463) Buprenorphine [Presence] in Urine

110

1.68

1.84

10.5

8.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

190

0.53

1.83

2.5

2.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

229

1139

1.20

1.82

2.6

2.9

37.3

39.8

0.71

423

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

216

1069

1.20

1.82

1.4

u/l

12.7

12.3

0.43

209

1033

(3014271) Vancomycin [Susceptibility]

163

784

1.24

1.81

3.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

245

1.43

1.79

1.2

1.5

nmol/l

110877.6

137380.1

0.07

198

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1066

6851

0.92

1.78

1.3

miu/ml

214.8

225.6

0.37

379

3214

(4015189)

100

454

1.31

1.77

1.8

2.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

226

1127

1.19

1.76

2.7

2.0

95.7

98.5

0.52

212

1041

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

192

1.49

1.76

2.1

2.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

299

1528

1.16

1.75

1.2

u/ml

55.8

46.2

0.24

108

(3029075) Extractable nuclear Ab panel - Serum

115

534

1.28

1.73

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

185

908

1.21

1.71

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

179

1285

0.83

1.71

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

395

2664

0.88

1.71

1.4

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

298

1526

1.16

1.71

1.2

u/ml

49.1

75.4

1.02

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

137

653

1.25

1.68

2.5

2.1

185.3

158.4

1.84

132

610

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

453

1.30

1.68

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

453

1.30

1.68

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

453

1.30

1.68

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

453

1.30

1.68

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

532

1.27

1.67

1.2

1.3

38.9

39.8

0.09

358

(3020891) Body temperature

1186

6563

1.08

1.66

5.2

5.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

343

1780

1.15

1.65

1.3

mmol/l

11.2

12.0

0.90

117

400

(3027944) Amphetamines [Presence] in Urine

1369

8685

0.93

1.64

2.9

2.2

—

(3000285) Sodium [Moles/volume] in Blood

190

0.56

1.63

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

299

0.66

1.60

1.1

u/ml

0.2

1.9

1.04

202

(3006840) Garlic IgE Ab [Units/volume] in Serum

0.00

1.59

0.0

1.0

—

0.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

363

1897

1.14

1.59

3.5

3.3

nmol/l

5.6

8.3

0.42

348

1840

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

416

1.30

1.57

1.4

1.6

ug/l

0.3

0.4

1.02

290

(3010838) Calcium [Moles/time] in 24 hour Urine

180

891

1.20

1.56

1.7

1.5

mmol/24h

4.7

5.6

—

(4268621)

370

1940

1.14

1.55

2.2

2.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.68

1.55

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.80

1.54

2.1

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

272

1397

1.16

1.53

1.9

2.0

mg/l

4.3

3.6

1.44

253

1335

(3036603) Volume of Urine

220

1111

1.18

1.53

1.8

1.7

1961.3

1978.9

0.05

254

(3020650) Glucose [Presence] in Urine

545

0.75

1.53

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

286

1475

1.15

1.53

1.2

u/ml

2.1

9.4

1.89

(3023383) Lactate [Moles/volume] in Pleural fluid

429

1.29

1.51

1.2

1.3

mmol/l

3.9

3.5

0.47

395

(3000330) Specific gravity of Urine by Test strip

1480

8285

1.06

1.51

4.0

3.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.26

1.48

1.1

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

2.16

1.48

1.2

—

35.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.68

1.48

1.5

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

186

1309

0.84

1.48

1.1

iu/ml

10.4

7.9

0.77

325

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

293

0.67

1.47

2.3

2.5

u/field

0.5

0.6

0.20

293

(3018851) Theophylline [Moles/volume] in Serum or Plasma

132

1.53

1.47

1.9

1.7

umol/l

47.7

48.0

0.02

132

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2099

13095

0.95

1.46

2.4

au/ml

25.7

22.4

0.40

745

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

307

1.34

1.46

5.1

5.4

ug/min

50.1

45.1

0.29

242

(3037556) Urate [Mass/volume] in Serum or Plasma

112

532

1.25

1.46

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

168

1191

0.84

1.46

1.0

—

(3024263) Appearance of Synovial fluid

193

969

1.18

1.46

1.7

1.8

—

(3025941) Bacteria identified in Stool by Culture

1875

11729

0.95

1.45

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

216

1.40

1.45

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

560

0.76

1.45

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1589

8933

1.06

1.43

3.0

2.7

e6/l

0.2

0.3

0.40

1559

8668

(3032057) Clostridioides difficile [Presence] in Stool

381

1.30

1.42

1.7

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

836

0.81

1.41

1.2

1.3

—

(44806071)

268

1.35

1.41

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

473

2538

1.11

1.37

1.6

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

441

1.27

1.37

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

234

1.37

1.36

1.0

—

(44813793)

216

1490

0.86

1.36

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

244

1257

1.15

1.36

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

153

758

1.20

1.36

2.5

2.3

umol/l

49.4

52.7

0.71

121

621

(3016018) Differential panel - Cerebral spinal fluid

371

1966

1.12

1.35

1.3

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

367

1947

1.12

1.32

4.7

9.0

mmol/l

7.2

0.16

301

1606

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

518

2800

1.10

1.32

1.5

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.60

1.31

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

112

1.54

1.31

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

292

0.69

1.31

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

925

5127

1.07

1.31

1.9

2.2

mg/l

11.6

10.6

3.03

862

4817

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.75

1.30

2.0

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

686

3759

1.09

1.30

3.0

2.4

16.4

16.6

0.79

389

1870

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

201

1.39

1.29

1.3

1.4

12.8

10.2

0.34

102

(3004616) Nuclear Ab [Presence] in Serum

449

2413

1.11

1.29

1.3

—

(4024509)

334

1766

1.13

1.28

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

1.77

1.28

1.2

1.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

304

0.70

1.27

1.2

1.1

u/ml

0.2

4.8

1.11

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

210

1441

0.87

1.26

1.9

u/field

1.5

2.4

1.73

102

705

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

825

1.18

1.25

2.0

1.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

123

1.50

1.25

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

445

2396

1.11

1.24

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

189

963

1.17

1.24

1.1

miu/ml

1465.0

1514.8

0.24

189

963

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

225

1162

1.15

1.24

1.6

1.4

u/l

5.7

5.6

0.11

202

990

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

200

1024

1.16

1.24

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

1407

8821

0.95

1.22

2.9

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

275

1.32

1.22

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

665

3652

1.08

1.21

1.3

1.4

u/l

30.5

26.5

2.20

512

3008

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

359

1.28

1.21

1.3

1.4

24.7

23.7

0.11

311

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

1.21

0.0

1.1

—

69.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

139

1.45

1.20

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

266

1.32

1.19

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

795

4401

1.08

1.19

2.4

2.1

—

(3022670) pH of Venous cord blood

0.00

1.18

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

334

1778

1.12

1.17

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

197

1013

1.16

1.17

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

195

1336

0.87

1.17

1.6

1.5

umol/l

62.0

67.1

—

101

(21494815) CD4 cells/100 lymphocytes in Specimen

316

1678

1.12

1.16

2.4

2.1

39.6

40.9

0.17

228

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1471

1.13

1.15

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

279

1471

1.13

1.15

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

232

1.33

1.14

1.0

—

(3022621) pH of Urine by Test strip

2017

12502

0.96

1.13

2.9

2.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

279

1474

1.13

1.12

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

241

1262

1.14

1.12

1.3

1.4

umol/l

13.4

11.8

2.81

223

1204

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

675

4317

0.93

1.11

1.4

pmol/l

157.0

111.7

1.20

656

4213

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

122

1.46

1.10

4.9

5.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

377

0.76

1.10

2.0

1.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

265

1769

0.89

1.09

4.2

4.6

u/ml

73.7

114.3

0.74

526

(3041672) Baker's yeast Ab [Presence] in Serum

1.56

1.07

1.0

—

(40765096) Chromosome analysis panel by Banding

102

500

1.21

1.07

1.2

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.48

1.07

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1486

1.12

1.06

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1486

1.12

1.06

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

907

5071

1.06

1.05

1.3

u/ml

6.7

7.6

0.23

129

805

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

656

3628

1.08

1.04

1.2

titre

169.1

141.4

0.13

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1407

7968

1.05

1.04

2.0

2.1

u/l

40.1

39.7

0.25

1244

7236

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1489

1.12

1.03

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.08

1.01

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.08

1.01

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

311

1667

1.11

1.00

1.2

—

(3017509) Phencyclidine [Presence] in Urine

248

1.29

1.00

2.5

1.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.52

0.99

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

212

1.32

0.99

4.6

3.2

umol/l

38.7

42.5

0.71

181

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

341

1839

1.10

0.98

1.6

30.9

32.3

0.29

212

1103

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

171

1.36

0.98

1.9

mmol/l

1.1

1.2

0.07

106

(3016330) Potassium [Moles/time] in 24 hour Urine

309

0.75

0.98

1.3

—

66.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

141

1.39

0.97

2.8

3.3

pmol/l

356.8

77.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

126

1.42

0.96

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.92

0.96

2.4

2.2

—

(3028300) Cannabinoids [Presence] in Urine

1422

8842

0.95

0.96

3.0

2.3

—

(3051593) INR in Capillary blood by Coagulation assay

144

739

1.16

0.93

8.3

9.4

—

(3000764) Benzodiazepines [Presence] in Urine

1413

8775

0.96

0.91

2.9

2.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

165

1119

0.88

0.91

1.1

u/l

1.0

0.33

477

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

326

1.24

0.91

2.5

2.8

mg/l

70.2

39.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

979

5518

1.06

0.90

1.3

u/ml

33.0

35.7

0.12

339

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

133

1.39

0.90

1.0

1.1

u/l

7.2

8.0

0.24

133

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

277

1487

1.11

0.90

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

479

2638

1.08

0.89

3.9

3.8

u/ml

27.0

38.3

1.77

467

2534

(3028714) Urate [Moles/time] in 24 hour Urine

1.86

0.89

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.86

0.89

1.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

131

0.64

0.88

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

598

0.83

0.87

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

243

1.27

0.87

1.4

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.77

0.85

1.0

1.2

2.9

2.6

0.07

(3030313) Adrenal Ab [Titer] in Serum

193

0.71

0.85

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

326

1773

1.09

0.83

1.4

e6/l

116276.7

100935.7

0.16

228

1190

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

287

0.77

0.83

2.0

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

115

587

1.17

0.83

1.1

1.3

33.1

19.5

0.86

100

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

132

681

1.15

0.83

3.0

2.8

umol/l

29.9

27.5

1.76

525

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

241

1292

1.11

0.82

1.1

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.82

0.0

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

412

1.20

0.82

1.2

1.4

4.8

2.7

0.92

352

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

886

4998

1.06

0.82

1.3

u/ml

9.2

4.7

0.61

528

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.82

0.0

1.6

—

(3028433) Virus identified in Specimen by Culture

127

654

1.15

0.82

1.1

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

299

1.23

0.81

4.9

4.2

u/l

72.9

60.3

0.23

107

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1102

6254

1.05

0.81

2.0

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

536

2979

1.07

0.81

1.2

—

(3019977) pH of Arterial blood

184

973

1.12

0.81

2.6

2.7

7.4

0.72

316

(3036670) Protein [Mass/volume] in Synovial fluid

101

512

1.17

0.80

1.2

1.3

g/l

40.8

39.6

0.32

269

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.45

0.79

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method

1050

5956

1.05

0.79

4.7

3.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1001

6239

0.95

0.79

1.4

u/l

11.5

10.2

1.89

809

5152

(4062490)

329

2127

0.92

0.79

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

184

975

1.12

0.79

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

171

1142

0.89

0.78

6.0

6.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

187

993

1.12

0.77

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

127

1.36

0.77

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

119

0.65

0.76

1.0

u/ml

0.2

0.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

195

1.28

0.76

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

331

2135

0.92

0.76

1.3

1.4

g/l

3.0

0.07

240

1460

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

133

0.67

0.76

1.1

nmol/l

13.5

15.9

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

169

1.30

0.76

1.7

1.5

ug/l

125.3

114.7

0.21

133

(3024139) IgG subclass 3 [Mass/volume] in Serum

331

2134

0.92

0.76

1.3

1.4

g/l

0.4

0.70

240

1468

(3027135) IgG subclass 1 [Mass/volume] in Serum

331

2134

0.92

0.76

1.3

1.4

g/l

6.5

6.8

0.72

241

1460

(4094501)

823

4648

1.05

0.75

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.57

0.74

1.0

pmol/l

111.9

156.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

393

0.82

0.74

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

108

1.38

0.73

1.6

2.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

1428

1.10

0.73

2.6

2.7

e6/l

713.3

749.5

0.16

103

612

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

392

0.82

0.72

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

392

0.82

0.72

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1959

12012

0.97

0.72

1.3

au/ml

45.3

45.7

0.02

452

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

165

0.72

0.70

1.0

u/ml

0.0

0.3

0.85

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

174

927

1.12

0.70

2.5

2.0

150.7

141.6

0.80

163

868

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

325

1785

1.08

0.70

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

166

1.29

0.70

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.70

0.70

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

812

4596

1.05

0.70

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

102

0.64

0.70

1.2

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

144

759

1.13

0.70

2.7

2.4

nmol/l

147.3

149.9

0.11

126

661

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

156

1.30

0.69

1.4

1.3

ml/s/173m2

1.4

1.6

0.16

100

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

184

985

1.11

0.69

1.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.42

0.69

1.5

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

377

1.18

0.68

1.2

1.4

26.7

21.7

0.72

347

(3043410) Blood group antigens tested for on Red Blood Cells

499

1.16

0.67

2.5

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

115

1.34

0.67

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

741

4192

1.05

0.66

4.3

3.9

kpa

8.6

8.8

0.96

729

4098

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.60

0.66

1.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

147

1.29

0.65

1.2

1.3

27.5

26.3

0.06

110

(3039162) Centromere protein B Ab [Units/volume] in Serum

436

2431

1.07

0.65

1.2

1.3

u/ml

53.9

55.3

0.04

176

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.57

0.64

1.2

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

111

1.34

0.64

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

135

714

1.12

0.64

1.5

1.4

pmol/l

15.3

14.7

0.22

107

596

(3018133) Calcium [Moles/volume] in Urine

260

1.21

0.64

1.5

1.7

mmol/l

2.8

2.7

0.09

235

(3048689) Calprotectin [Mass/mass] in Stool

4197

25417

0.98

0.63

2.3

2.4

ug/g

151.1

126.8

2.46

3282

19999

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

185

997

1.10

0.63

1.6

1.5

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.63

0.0

1.0

—

7.3

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.0

—

3.1

—

(3022475) Manganese [Moles/volume] in Blood

0.66

0.62

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

171

1122

0.91

0.61

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1101

1.10

0.61

1.6

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

256

1.21

0.61

1.4

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

947

5862

0.96

0.61

1.8

nmol/l

40.1

39.9

0.10

907

5734

(3036071) Salmonella sp Ab [Titer] in Serum

116

611

1.13

0.60

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

1.78

0.59

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.36

0.59

1.6

u/l

0.0

0.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

330

0.83

0.58

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

123

652

1.12

0.58

1.4

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.40

0.58

1.4

1.5

—

(3013762) Body weight Measured

1.40

0.58

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.46

0.57

1.2

1.1

mmol/l

—

(3028271) Lactate [Moles/volume] in Capillary blood

503

2833

1.06

0.56

2.0

1.8

mmol/l

1.7

0.93

491

2770

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.57

0.56

1.0

3.1

mu/l

3.4

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7493

43999

1.02

0.56

1.3

u/ml

1.8

1.7

0.19

1886

12360

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

558

1.13

0.56

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

558

1.13

0.56

2.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

308

1.18

0.56

2.6

2.2

—

(3012501) Base excess in Blood by calculation

733

4169

1.05

0.56

4.2

3.9

mmol/l

2.5

2.4

0.38

489

2827

(3013290) Carbon dioxide [Partial pressure] in Blood

733

4170

1.05

0.56

4.3

3.9

kpa

5.0

0.02

722

4076

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

194

1.23

0.55

2.3

2.2

—

(3014891) Appearance of Pleural fluid

162

1.25

0.55

1.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

177

0.77

0.54

1.0

u/ml

0.0

2.2

0.58

100

(3033923) Metanephrine [Moles/time] in 24 hour Urine

398

1.15

0.54

1.1

umol/24h

0.6

4.2

0.54

212

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.60

0.54

1.0

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

116

0.72

0.54

1.1

1.4

1.3

1.7

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.42

0.53

1.1

1.0

u/ml

0.4

0.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1031

5914

1.04

0.53

1.9

1.7

g/l

0.2

1.09

974

5629

(3020393) Adenovirus Ag [Presence] in Stool

183

0.78

0.53

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.55

0.53

1.0

—

(3003577) Lead [Moles/volume] in Blood

147

1.25

0.52

1.2

1.5

umol/l

0.1

0.2

2.30

(40758047) Lysozyme [Mass/volume] in Pleural fluid

110

1.30

0.52

1.0

1.1

mg/l

10.8

10.0

0.12

(3016031) Almond IgE Ab [Units/volume] in Serum

122

0.73

0.52

1.0

u/ml

0.1

0.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

421

0.86

0.52

1.2

1.3

mg/l

0.8

32.3

1.76

313

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

971

5569

1.04

0.51

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

522

0.88

0.51

2.8

2.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

177

965

1.09

0.51

1.6

1.5

4.0

4.1

0.02

210

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

108

0.72

0.51

1.0

1.3

—

16678.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

377

2115

1.06

0.51

1.2

—

(3016879) Cocaine [Presence] in Urine

1340

8204

0.97

0.50

3.0

2.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

214

0.81

0.50

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

121

0.74

0.50

1.0

u/ml

0.1

0.9

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.33

0.49

1.0

u/ml

0.0

0.1

—

(3004451) EKG impression Narrative

153

831

1.09

0.49

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

327

1830

1.06

0.48

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.61

0.47

1.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.58

0.47

6.4

5.0

mmol/l

0.3

0.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

212

0.81

0.47

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

226

1.18

0.46

1.0

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

248

1.17

0.46

1.8

1.3

titre

103.3

215.1

—

(3016750) Collection duration of Urine

170

931

1.09

0.46

2.4

2.2

min

490.3

506.9

1.42

129

683

(3001686) Cold agglutinin [Titer] in Serum or Plasma

298

1.16

0.46

1.2

1.3

titre

92.0

138.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

172

0.79

0.46

1.0

u/ml

0.0

0.2

0.82

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

304

1.15

0.45

1.9

mmol/l

1.2

0.43

291

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

491

0.88

0.45

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1570

9568

0.97

0.45

3.2

3.0

u/ml

40.7

44.1

0.27

1511

9197

(3014765) Yersinia sp identified in Stool by Organism specific culture

978

5630

1.03

0.45

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

113

1.26

0.45

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

121

790

0.91

0.44

1.4

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

117

631

1.10

0.44

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.49

0.44

1.1

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.49

0.44

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

157

1012

0.92

0.44

1.1

u/ml

8.1

7.5

0.07

168

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

726

4160

1.04

0.43

1.2

1.3

mmol/l

3.9

3.7

2.48

684

3919

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

423

1.12

0.43

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.71

0.43

1.0

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

288

1614

1.06

0.43

2.3

1.9

nmol/l

18.1

18.5

0.30

268

1522

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.43

0.0

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.27

0.42

1.0

u/ml

0.0

0.1

—

(1002224) Polysomnography panel

1408

8581

0.97

0.42

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

125

1.24

0.42

1.8

0.9

0.04

(3001556) Androgen free Index in Serum or Plasma

218

1.17

0.41

1.2

1.4

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

109

1.25

0.41

1.0

1.1

u/ml

39.8

27.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

136

1.22

0.41

1.0

1.1

iu/ml

13.6

15.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

686

0.91

0.41

1.1

90.1

91.9

0.19

336

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.49

0.40

1.2

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.41

0.40

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

370

1.12

0.39

2.5

2.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

128

699

1.09

0.39

1.1

1.2

114.6

110.0

1.20

110

631

(42529406) Shigella sp [Presence] in Stool by Culture

977

5641

1.03

0.39

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

183

1015

1.07

0.39

1.1

1.3

u/l

364.2

274.9

0.55

164

933

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13703

81930

0.99

0.38

3.2

2.9

ug/l

134.3

114.0

14.32

12574

76698

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.37

0.38

1.0

1.3

ng/l

2413.5

3977.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

165

1.19

0.38

1.3

1.4

pmol/l

17.1

9.5

0.92

136

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

181

1005

1.07

0.38

1.1

u/ml

28.8

12.1

0.44

(4133840)

102

553

1.10

0.37

1.3

1.2

—

(3019174) dRVVT (LA screen)

182

1.18

0.37

1.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

327

1.13

0.37

2.0

mmol/l

1.2

1.01

311

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

227

1431

0.94

0.37

1.3

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

819

4723

1.03

0.37

1.3

mg/l

557.9

526.8

0.25

787

4494

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

111

1.23

0.37

1.1

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

111

1.23

0.37

1.2

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

134

0.80

0.36

1.8

1.5

12.0

13.5

0.17

104

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

1.33

0.35

1.2

1.6

nmol/l

209.4

213.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

117

1.22

0.35

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

413

1.11

0.35

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

128

1.21

0.35

3.6

6.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

121

664

1.08

0.35

2.4

2.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

204

0.84

0.35

1.2

1.3

mmol/l

8.0

5.8

—

(3028717) Thiamine [Mass/volume] in Blood

211

1.16

0.35

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

226

1421

0.94

0.35

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

191

0.84

0.34

1.0

u/ml

0.0

0.2

1.17

109

(3044009) aPTT.lupus sensitive (LA screen)

189

1.16

0.34

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

1.19

0.34

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

715

4122

1.03

0.34

1.3

1.4

e6/l

35.4

31.5

0.08

542

3236

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.67

0.34

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1050

6089

1.03

0.33

1.9

1.7

g/l

1.2

0.28

996

5821

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

107

1.22

0.33

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

115

632

1.08

0.33

2.3

1.9

—

(3025130) Human papilloma virus identified in Specimen

501

2873

1.04

0.33

1.8

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

820

4742

1.03

0.32

1.9

iu/l

4.1

10.7

0.78

287

1754

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

715

4127

1.03

0.32

1.4

e6/l

2509.4

2565.3

0.01

577

3417

(3006270) Folate [Moles/volume] in Blood

218

1368

0.95

0.32

1.2

nmol/l

391.2

370.6

0.77

166

1192

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

259

0.87

0.32

1.4

41.3

50.8

0.47

138

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

175

1105

0.94

0.32

1.3

g/l

1.3

1.5

—

(3000012) Reticulocyte production index

161

898

1.07

0.32

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.34

0.31

1.1

1.0

nmol/24h

73.6

106.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.25

0.31

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

562

3235

1.03

0.31

1.5

g/l

0.7

0.82

433

2396

(3001218) Citrate [Mass/time] in 24 hour Urine

1.30

0.31

1.6

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.30

0.31

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

114

1.20

0.30

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

124

0.81

0.30

1.1

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.72

0.30

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1758

10626

0.98

0.29

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

263

0.88

0.29

1.1

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

402

1.09

0.29

1.1

1.2

82.7

78.1

0.28

113

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

187

1.14

0.29

2.3

2.6

mg/l

1.9

1.2

0.71

125

(3002621) Streptococcal DNAse B [Units/volume] in Serum

148

1.16

0.28

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

272

1548

1.04

0.28

1.2

1.3

mmol/l

2.1

2.0

0.40

254

1432

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

148

0.84

0.27

1.7

1.5

36.5

38.1

0.06

108

(3016228) CD19 cells/100 cells in Blood

145

812

1.06

0.27

2.4

2.0

7.9

8.7

0.31

140

795

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.27

0.26

1.0

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

197

1115

1.05

0.26

1.3

1.4

mmol/l

5.9

5.6

2.19

182

1041

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

177

999

1.05

0.26

1.2

1.3

46.7

62.3

1.39

120

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

144

1.16

0.26

3.3

2.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

185

0.87

0.26

1.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

109

692

0.94

0.26

1.1

107.8

111.1

0.38

100

622

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.28

0.24

1.3

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

209

0.88

0.24

1.4

2.3

mmol/l

6.8

6.9

—

(3001729) Color of Synovial fluid

145

1.15

0.24

1.8

1.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.35

0.24

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

665

0.94

0.24

1.1

95.7

94.3

0.12

327

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.29

0.23

1.2

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1204

7280

0.98

0.23

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

183

0.88

0.23

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

239

0.90

0.23

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5259

31490

0.99

0.22

1.8

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

375

0.92

0.22

4.4

2.3

ng/l

62.7

107.2

2.79

175

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.22

0.0

1.5

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.22

0.0

1.3

—

21.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

169

959

1.05

0.22

1.5

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

294

0.91

0.22

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

169

0.88

0.21

1.6

mg/l

1.0

2.0

1.33

110

(3044290) Cell count panel - Cerebral spinal fluid

670

3898

1.02

0.21

1.3

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

252

1445

1.04

0.21

2.3

2.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

164

1.12

0.21

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

197

1124

1.04

0.21

1.1

nmol/l

3.8

4.8

0.30

196

(40762814) Titanium [Mass/volume] in Blood

305

0.92

0.20

2.2

2.3

ug/l

5.1

3.5

0.38

119

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.23

0.20

1.2

1.1

titre

1168.3

1982.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

311

0.92

0.20

1.5

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

118

739

0.95

0.20

1.1

ng/l

1030.6

838.6

0.10

152

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.18

0.19

1.0

1.1

mg/l

0.0

0.6

0.51

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

433

0.93

0.19

1.1

1.2

97.7

94.6

0.49

424

(3012494) Peanut IgE Ab [Units/volume] in Serum

549

0.94

0.19

1.1

u/ml

0.5

3.5

1.12

293

(3013247) Albumin in CSF/Albumin in Serum or Plasma

406

1.07

0.19

1.1

mg/g

6.6

6.3

0.15

382

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.21

0.19

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

554

0.94

0.18

1.5

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1133

6833

0.99

0.18

1.6

1.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.17

0.18

1.1

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

407

1.07

0.18

1.2

90.1

90.0

0.01

121

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.15

0.18

1.6

1.7

umol/l

0.5

0.7

1.37

(3038177) Helicobacter pylori Ab [Presence] in Serum

518

3146

0.98

0.18

1.3

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

269

1.08

0.18

1.3

1.2

nmol/l

0.3

0.10

185

(3012565) Volume of 24 hour Urine

173

989

1.04

0.18

2.3

1939.9

1997.6

0.29

158

889

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

143

814

1.04

0.18

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.21

0.18

1.1

1.2

nmol/l

322.3

243.7

0.52

(1175426) CD3 cells/100 lymphocytes in Blood

270

1557

1.03

0.17

2.3

2.1

74.8

72.9

1.24

254

1500

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

145

826

1.04

0.17

3.5

3.9

—

(3029612) Listeria sp Ab [Titer] in Serum

0.74

0.17

1.0

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

1.10

0.17

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

125

777

0.96

0.17

1.7

1.9

mg/l

8.7

9.3

0.63

100

605

(3034092) Cytoplasmic Ig cells/100 cells in Blood

270

1.08

0.17

8.6

8.0

—

(3050794) Legionella sp Ab [Presence] in Serum

144

1.11

0.17

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

246

0.92

0.16

1.3

—

(40768793) Breast Pathology biopsy report

650

3795

1.02

0.16

1.3

—

(4027681)

216

1243

1.03

0.16

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

399

0.94

0.16

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

130

741

1.04

0.16

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

294

1.07

0.16

2.2

1.7

pmol/l

39.8

64.3

0.76

246

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.85

0.15

1.2

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

140

800

1.04

0.15

2.4

2.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

407

2367

1.02

0.15

1.9

1.8

89.6

90.1

1.04

401

2324

(3034614) HLA Ag [Interpretation]

0.80

0.15

1.6

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

265

1534

1.03

0.15

2.3

2.1

14.1

14.8

0.21

118

706

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

1129

0.97

0.14

1.5

2.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

723

4234

1.02

0.14

2.0

pmol/l

189.6

198.9

1.42

683

4018

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

429

1.05

0.14

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

342

1.06

0.14

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

133

762

1.04

0.14

2.5

2.6

au/ml

179.6

162.5

0.15

111

(3010421) pH of Blood

824

4832

1.01

0.14

4.2

3.8

7.4

0.45

722

4079

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

267

1.07

0.14

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

213

1232

1.03

0.13

2.9

2.7

e9/l

0.3

0.4

0.11

205

1204

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

547

1.04

0.13

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

244

1415

1.03

0.13

1.7

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

130

800

0.97

0.13

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

1.19

0.12

3.2

2.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

181

0.92

0.12

1.3

1.4

63.6

69.9

0.38

157

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

507

1.04

0.12

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

8309

49227

1.00

0.12

4.3

4.1

estimate

0.0

0.72

3060

17345

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

243

1411

1.02

0.12

2.6

e6/l

619.2

534.5

0.86

203

1204

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

430

0.95

0.12

1.1

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

180

1041

1.03

0.12

2.0

ug/l

4.8

3.6

0.63

159

925

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

211

0.93

0.12

1.1

umol/24h

1.7

3.4

0.48

211

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

1.5

0.9

0.31

102

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

1.8

1.6

0.07

112

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

2.9

3.0

0.01

113

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

1.2

1.1

0.01

100

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

3.0

2.5

0.13

108

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

3.7

2.0

0.32

106

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

1.4

1.7

0.28

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

4.3

3.8

0.16

105

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

162

0.92

0.12

1.6

mg/l

1.4

1.8

0.23

122

(3013166) Neutrophils/100 leukocytes in Synovial fluid

104

596

1.04

0.11

1.5

1.4

52.1

53.1

0.09

505

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2124

12540

1.01

0.11

3.2

3.3

pmol/l

4.5

0.01

1851

11285

(40763590) HLA-DQ beta [Type]

1.13

0.11

1.0

—

(3013862) HLA-DP [Type]

1.13

0.11

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

544

1.04

0.11

2.1

e6/l

180.4

286.7

0.40

292

(3020491) Glucose [Moles/volume] in Blood

239

1452

0.98

0.11

1.7

mmol/l

7.0

6.8

0.58

163

1078

(1001926) Buprenorphine [Presence] in Urine by Screen method

1140

6839

0.99

0.11

3.2

2.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

317

1.05

0.10

2.2

1.9

ug/l

2.4

2.8

0.15

188

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

633

0.97

0.10

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

640

3759

1.01

0.10

5.3

4.0

—

(3025577) Chromium [Mass/volume] in Blood

175

1015

1.02

0.10

2.0

2.1

ug/l

2.5

2.4

0.19

146

849

(3005011) Chlamydia sp Ab [Titer] in Serum

259

1.06

0.10

1.5

1.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

143

1.08

0.10

1.1

—

2.1

—

(3040794) Aluminum [Moles/volume] in Urine

1.10

0.10

1.2

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

132

763

1.03

0.10

2.1

32.4

29.2

1.42

120

724

(36303858) Crystals [Presence] in Urine

1.06

0.09

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

154

0.93

0.09

1.0

u/ml

0.3

0.2

—

(46236302) HLA-C [Type] by High resolution typing

1.11

0.09

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

219

1.06

0.09

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

134

776

1.03

0.09

2.2

9.1

9.9

0.45

119

724

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

693

4160

0.99

0.08

1.3

1.2

u/ml

45.5

43.3

0.12

416

(3042010) Triglyceride [Moles/volume] in Pleural fluid

238

0.95

0.08

1.1

1.2

mmol/l

0.5

1.0

1.09

150

(3011412) CD3 cells [#/volume] in Blood

336

1969

1.01

0.08

2.7

2.5

e9/l

1.2

0.25

202

1192

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.04

0.08

1.0

u/l

1100.0

158.1

—

(3051339) Copper [Moles/volume] in Blood

104

1.09

0.08

1.1

1.2

umol/l

17.5

17.2

0.09

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.81

0.08

1.0

1.1

u/field

1.7

0.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

175

1020

1.02

0.07

1.2

1.3

umol/l

3.8

4.8

3.15

152

951

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

250

1.05

0.07

1.7

1.8

mg/l

1.9

1.6

0.44

212

(3052592) Norovirus Ag [Presence] in Stool

385

1.03

0.07

1.4

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

268

1570

1.01

0.07

1.1

mg/l

257.9

256.3

0.05

244

1367

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

185

1080

1.02

0.07

1.8

u/field

2.7

2.0

0.31

109

808

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

106

646

0.98

0.07

1.5

1.6

au/ml

170.4

130.2

0.23

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

146

0.94

0.07

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

279

0.96

0.07

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

302

1818

0.99

0.06

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.89

0.06

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

339

1.03

0.06

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

252

1518

0.99

0.06

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.09

0.06

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

115

0.93

0.06

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

516

1.03

0.06

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

512

0.98

0.06

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

233

1367

1.01

0.05

2.7

e9/l

0.2

0.23

201

1203

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

523

0.98

0.05

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

517

0.98

0.05

1.2

1.3

nmol/l

175.5

119.5

0.67

394

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

441

1.02

0.05

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

654

3863

1.01

0.05

1.7

—

(40757373) Influenza virus identified in Isolate

347

1.03

0.05

1.7

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

204

1227

0.99

0.04

1.1

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.08

0.04

1.6

1.1

umol/24h

1.9

0.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

204

0.96

0.04

1.1

1.3

u/l

1108.2

276.4

0.34

153

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

130

761

1.02

0.04

1.1

1.2

g/l

0.3

3.76

100

599

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

277

1.03

0.04

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

185

1087

1.01

0.04

1.6

1.5

ug/l

8.4

8.1

0.06

159

984

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.04

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

236

1.03

0.04

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

121

730

0.99

0.04

1.4

mu/l

534.2

783.6

0.80

114

690

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

461

0.98

0.04

1.8

1.9

u/l

22.1

25.8

0.29

414

(3013005) Retinol [Moles/volume] in Serum or Plasma

131

768

1.01

0.04

1.6

1.7

umol/l

2.1

2.0

0.64

123

730

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.93

0.03

1.2

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.09

0.03

1.3

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

107

0.94

0.03

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

107

1.06

0.03

1.6

1.3

mmol/l

22.9

23.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

134

806

0.99

0.03

3.0

3.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

243

1.03

0.03

2.6

2.7

pmol/l

135.8

58.8

0.69

206

(3024316) Viscosity of Plasma

1.07

0.03

1.4

2.0

mpas

1.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

304

0.98

0.03

1.1

1.0

ug/l

88.7

83.0

0.45

250

(3016244) Insulin [Units/volume] in Serum or Plasma

210

1239

1.01

0.02

2.9

3.3

mu/l

31.0

28.4

0.37

193

1167

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

510

1.01

0.02

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

118

0.96

0.02

1.8

1.6

umol/24h

321.2

364.2

0.41

118

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

106

0.95

0.02

1.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

124

744

0.99

0.02

1.4

73.4

73.2

0.04

117

704

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

197

1.03

0.02

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

139

833

0.99

0.02

2.9

3.0

mg/l

8.4

7.9

0.42

117

643

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

386

0.99

0.01

1.2

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

225

0.98

0.01

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.06

0.01

1.4

1.5

nmol/l

559.4

489.7

0.14

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

126

743

1.01

0.01

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

114

672

1.01

0.01

3.1

2.2

ug/l

1.1

0.02

109

623

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

352

1.01

0.01

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

221

1308

1.00

0.01

1.8

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

385

0.99

0.01

2.7

2.4

mmol/l

7.8

7.1

0.71

223

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

274

1623

1.00

0.01

1.2

1.1

mg/l

38.0

40.4

0.43

231

1366

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

160

946

1.01

0.01

1.0

1.1

101.4

97.8

0.71

130

771

(3046861) Legionella sp Ag [Presence] in Urine

0.96

0.01

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

293

1.01

0.01

1.1

u/ml

0.9

0.1

0.62

176

(40761539) Cells [Type] in Urine sediment by Light microscopy

489

1.01

0.01

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

115

1.03

0.01

1.2

1.3

ug/l

137.8

94.0

0.86

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

697

1.01

0.00

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1710

10170

1.00

0.00

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

378

0.99

0.00

1.3

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.96

0.00

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.97

0.00

1.0

1.6

ug/g

145.8

174.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

185

1.00

0.00

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

114

0.99

0.00

1.0

1.1

u/field

1.1

—

(40760410) HLA-B [Type] by High resolution

1.04

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

1.04

0.00

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.00

0.00

1.1

—

(40758358) Immune stain study

0.96

0.00

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

290

1.00

0.00

1.1

1.2

mmol/l

1.7

1.8

0.21

177

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.99

0.00

1.8

2.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.02

0.00

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

635

1.00

0.00

3.4

—

(40758292) HTLV I+II Ab panel - Serum

318

1.01

0.00

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

507

3015

1.00

0.00

1.4

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.05

0.00

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.00

0.00

1.5

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

106

1.01

0.00

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

106

1.01

0.00

1.2

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

475

1.00

0.00

1.1

—

(4038314)

167

1.00

0.00

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

221

1317

1.00

0.00

1.1

ratio

1.1

0.17

484

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

101

1.00

0.00

1.4

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

260

1.01

0.00

3.2

3.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.96

0.00

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.91

0.00

1.3

1.2

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.97

0.00

1.0

u/ml

0.0

0.1

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

0.96

0.00

3.2

3.4

nmol/l

307.2

336.6

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.90

0.00

1.0

1.3

mg/l

24.2

27.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.87

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_PARODON_OPER_DENTAL_OPER and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_PARODON_OPER_DENTAL_OPER	1.034 [0.87, 1.22]	0.697
Birth year	0.996 [0.99, 1.0]	0.258

During the follow-up period (1.1.1998 — 31.12.2019), 4955 out of 105318 females with K11_PARODON_OPER_DENTAL_OPER died.

Males

Parameter	HR [95% CI]	p-value
K11_PARODON_OPER_DENTAL_OPER	1.132 [0.96, 1.34]	0.148
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 7302 out of 102277 males with K11_PARODON_OPER_DENTAL_OPER died.

Mortality risk

Mortality risk for people of age

years, who have K11_PARODON_OPER_DENTAL_OPER.

N-year risk	Females	Males
1	0.079%	0.189%
5	0.652%	1.256%
10	1.651%	3.119%
15	3.11%	5.877%
20	5.245%	9.77%

Relationships between endpoints

↥

Index endpoint: K11_PARODON_OPER_DENTAL_OPER – Parodontitis or/and operation codes

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Parodontitis or/and operation codes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints